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ABSTRACT
The goal of this project is to address limitations of coupled enzyme assays
using capillary electrophoresis (CE). In some enzyme assays, it is ineffective to directly
detect products and substrates spectroscopically (absorption or fluorescence).
Coupling the enzyme-catalyzed reaction of interest with another enzyme-catalyzed
reaction allows for indirect detection of product formation or substrate depletion for the
target enzyme. While conventional coupled enzyme assays are facile for kinetic
measurements, they can be problematic for inhibition screening due to spectral and
inhibitor interferences. To address these limitations of coupled assays, CE has been
used to develop enzyme assays for acetyl-coenzyme A carboxylase (ACC). The first
approach is to utilize CE to separate assay components (substrates, products, and
inhibitors) and avoid using coupling enzymes. In Chapter 2, a previously developed
bacterial holo-ACC assay was optimized and applied to study the inhibition of bacterial
holo-ACC, BC, and CT by five flavonols (myricetin, quercetin, anrantine osage orange,
galangin, and DHF). The IC50 values for these inhibitors were determined using offline
CE assays. A new offline assay developed for a human form of ACC, human ACC2,
is presented in Chapter 3. This assay was used to detect inhibition of the human
enzyme. The second approach is to use coupling enzymes, but in combination with
CE separation to reduce spectral interference and inhibitor interference with the
coupled reactions. The envisioned CE coupled enzyme assay will use a light emitting
diode (LED) as the excitation source for fluorescence detection of NADH consumption.
Although LEDs have been widely used as alternatives to lasers for fluorescence
detection, studies on the stability and noise associated with LEDs for CE detection are
limited. In Chapter 4, a 470-nm LED was quantitatively compared to argon ion laser
lines as a source for fluorescence detection with CE. Appendix 1 presents progress in

x

the development of the CE online coupled assay for ACC. This assay will use magnetic
beads as the solid support for immobilized the coupling enzymes, and the
fluorescence detection of NADH with LED excitation.

xi

CHAPTER 1. INTRODUCTION
1.1. Enzyme Catalysis, Inhibition and Assays
1.1.1. Enzyme Catalysis
Enzymes are biomolecules that catalyze chemical reactions to sustain life’s
critical functions in living entities. They are not only attractive targets for drug
development but also important ingredients for chemical, food, and brewing industries.
The vast majority of enzymes are proteins, except for catalytic ribonucleic acid
enzymes, or ribozymes [1, 2]. Without enzyme catalysis, some biochemical reactions
are too slow to maintain life functions. Protein enzymes accelerate reactions from 107to 1019-fold [3]. For example, orotidine 5’-monophosphate decarboxylase enhances
the decarboxylation of orotidine monophosphate to form uridine monophosphate by a
factor of 1017 [4]. Another enzyme, arginine decarboxylase, accelerates the
decarboxylation of L-arginine to form agmatine by 1019-fold [5].
Like all proteins, protein enzymes are built from amino acids. The assembling
of amino acids into a protein is defined in four levels: primary, secondary, tertiary and
quaternary structures. The primary structure is the linear polypeptide chain in which
the amino acid residues are covalently linked through amide bonds. The secondary
structure refers to the polypeptide chains folding into stable patterns such as alpha
helices, beta sheets, and occasionally turns, loops, or hairpins. This arrangement is
driven by hydrogen bonding between carboxyl groups and amino groups in close
proximity. The tertiary structure is the three-dimensional arrangement of a single
polypeptide chain. Finally, multiple polypeptide chains constitute subunits of the
quaternary structure.
An enzyme derives its catalytic ability by catalyzing the conversion of substrates
to products. The enzyme catalysis is initiated by the enzyme binding with a substrate
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molecule to form an enzyme-substrate complex. This step takes place in a binding
pocket or groove called the active site, which is relatively small compared to the total
volume of the enzyme. Active sites are hydrophobic microenvironments that possess
highly polarized functional groups [6]. Active sites usually have complementary shapes
and structures to the substrates. The binding of a substrate to the active site is
stabilized through weak noncovalent interactions such as electrostatic force, hydrogen
bonding, hydrophobic interactions, and van der Waals interactions. Upon binding, the
substrate is desolvated inside the active site and protected from the bulk aqueous
solution. A chemically active portion of the active site then acts upon and distorts the
enzyme-substrate bond. Consequently, changes in spatial orientation, bond length, or
bond strength transform the substrate to product(s) [6].
Enzyme catalysis is regulated by not only the active sites but also cofactors
which can be divided into two groups: metals and coenzymes. Metal ions such as Fe2+,
Mg2+, Zn2+, Ni2+, and K+ which serve as Lewis acid or an electron acceptor/donator
usually bind to either the enzyme or substrate. The metal-substrate complexes are
actual substrates for the enzymatic reactions. For example, Mg2+ is needed for acetyl
coenzyme A carboxylase-catalyzed reaction in which the Mg2+-ATP complex is the
actual substrate and Mg2+ also binds to the active site on the enzyme [7]. Coenzymes
are small organic compounds derived from vitamins, exemplified by biotin, which is
also known as vitamin B7. Biotin is responsible for the transfer of the carboxyl group
in carboxylase-catalyzed reactions [8]. A metal ion or a coenzyme that covalently
bonds with the enzyme is called a prosthetic group. The holistic enzyme bound with
metal ions or coenzymes is referred to as a holoenzyme [9].
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1.1.2. Enzyme Kinetics
Equation 1.1 shows the progress of an enzyme-catalyzed reaction, provided
that every step is reversible:
1.1
An enzyme-catalyzed reaction starts with the formation of a binary encounter
complex ES, also known as the Michaelis complex, by the binding of the enzyme (E)
to the substrate (S). Subsequently, the binary encounter complex ES goes through the
transition state (ES‡) and a bound product state (EP) before the product (P) and free
enzyme (E) are released. The change in free energy over the course of an enzymecatalyzed reaction is illustrated in Figure 1.1. Regardless of how negative the Gibbs
free energy (ΔG) is, the substrates must overcome the activation energy (Ea) in order
to be converted to the products. An enzyme functions through the formation of the
transition complex between the enzyme and substrate to lower the activation energy
(Ea’), leading to enhanced reaction rate while the reaction equilibrium remains
unchanged.
The series of reactions after the formation of binary encounter complex ES are
combined and represented as the conversion from ES to enzyme (E) and product (P).
The corresponding rate constant for this process, k2, predominantly depends on the
formation of the transition state complex ES‡. Equation 1.2 shows the simplified
enzymatic reaction:

1.2

The Michaelis-Menten model of enzyme kinetics is based on several
assumptions. First, the concentration of ES encounter complex is at steady state for a
prolonged time period. In this condition, a balance between rate of ES formation and
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rate of ES dissociation results in constant concentration of ES. Second, the reverse
reaction to convert product back to substrate is negligible, provided that at the early
stage of the enzymatic reaction, the concentration of product was relatively low.
Therefore, the product formation is assumed to be an irreversible and rate-determining
step. As a consequence, the change in ES concentration over time is calculated as:
d[ES]
= k1 [E][S] - k-1 [ES] - k2 [ES] = 0
dt

1.3

Transition state
Without enzyme

Free Energy, G

Ea
With enzyme

E a’

Substrate
ΔG

Product

Reaction coordinate

Figure 1.1. Energy diagram for enzymatic catalysis
The initial rate of reaction, measured as substrate depletion or product
formation, is proportional to ES complex concentration:
v=-

d[S] d[P]
=
= k2 [ES]
dt
dt

1.4

Provided that concentration of ES is constant under steady state conditions, the
initial rate of reaction is also constant and can be calculated as the slope of the linear
plot of [S[ or [P] versus reaction time. The constant ES level is practically established
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at high substrate concentration (micromolar to millimolar) relative to enzyme
concentration (nanomolar). In the initial phase of the reaction, only a small portion of
substrate depletes so the steady state condition is maintained. As the reaction
proceeds, more substrate is consumed and converted to more products. After this
point, the assumption of steady state does not apply, and the reaction rate slows down
until the product formation reach equilibrium. The plot of product concentration as a
function of time is shown in Figure 1.2.

[P] (M)

Equilibrium

Initial phase
Slope = v

T (min)

Figure 1.2. Schematic depiction of enzymatic reaction progress
At a fixed enzyme concentration, the dependence of the initial rate of reaction
on substrate concentration is described by the Henri and Michaelis-Menten models:
v=

Vmax [S]
Km +[S]

1.5

where v is the initial reaction rate, Vmax is the maximum reaction rate at an
infinite substrate concentration, [S] is the substrate concentration, and Km is the
Michaelis constant. Figure 1.3 illustrates the initial reaction rate as a function of
substrate concentration when the enzyme concentration is kept constant.
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v (M/min)

Km

[S] (M)

Figure 1.3. Schematic depiction of the dependence of reaction rate on substrate
concentration
When the substrate is added at a negligible concentration relative to Km,
Equation 1.5 can be simplified as:
v=

Vmax
[S]
Km

1.6

As such, the initial reaction rate is linearly proportional to substrate
concentration, and this linear portion has a slope of Vmax/Km. As the substrate
concentration increases well above Km, the initial rate of reaction reaches the
maximum level, Vmax. In this condition, the active sites of all enzyme molecules are
likely saturated by the substrate. At substrate concentration equivalent to Km, equation
1.5 becomes:
v=

Vmax [S] Vmax
=
[S]+[S]
2

1.7

Therefore, Km is equal to the substrate concentration at which the initial rate of
reaction equals half of the maximum rate.
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1.1.3. Enzyme Inhibition
Enzymes are essential for all life, but enzyme inhibition is an attractive target
for drug discovery. First of all, like other living entities, pathogens such as viruses,
bacteria, and fungi rely on enzymes to maintain their functions. Selectively inhibiting
certain enzymes in these pathogens is likely to disrupt their functions, weaken, and
even kill them. As such, enzyme inhibition in infectious agents is effective for treatment
of illness or infectious diseases of their hosts. In modern medicine, a plethora of
antibiotics, antiviral and anti-parasitic drugs function based on selective enzyme
inhibition [6]. Second, although enzymes are needed for biological functions, enzyme
overexpression or exceedingly high enzyme activity is linked to disease stages.
Mutation of genes encoding an enzyme can lead to abnormally high enzyme
concentration (enzyme overexpression) and consequently generates excessive
product concentrations. Alternatively, point mutations in an enzyme can result in
aberrantly high enzyme activity, also giving rise to high product formation. Therefore,
enzymes are an attractive target for intervention in many diseases [6].
In clinical use, a significant portion of drugs treat diseases through enzyme
inhibition. According to Hopkins and Groom, about 47% of small molecule drugs
available on market inhibit enzymes as their molecular targets [10]. Enzyme inhibitors
are mostly small molecules that keep the substrates from being converted to products
by binding to either the enzyme, substrate, or both. Enzymes are susceptible to
reversible or irreversible inhibition. Reversible inhibitors bind to the enzymes via weak,
non-covalent interactions such as hydrophobic interactions and hydrogen bonding.
Alternatively, irreversible inhibitors form strong covalent bonds with enzymes that
permanently alter the catalytic activity [6].
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Most drugs inhibit their target enzymes through reversible interactions.
Reversible enzyme inhibition proceeds in three modalities: competitive inhibition,
uncompetitive inhibition, and noncompetitive inhibition. Figure 1.4 shows the possible
pathways the inhibitor can take to inhibit an enzymatic reaction.
In competitive inhibition, the inhibitor shows exclusive affinity to the free
enzyme. Typically, a competitive inhibitor is a compound that resembles the substrate
with respect to chemical structure and molecular geometry. As a result, the inhibitor
and substrate are mutually exclusive as they compete for the active site. Binding of
the competitive inhibitor to the enzyme at the active site to form EI interferes with the
interaction of substrate with the enzyme. However, the binding of the enzyme to either
the inhibitor or substrate is reversible. Therefore, substrate at sufficiently high
concentration can dominantly bind to the enzyme and minimize the enzyme inhibition.
Consequently, competitive inhibition depends on concentrations of the substrate and
product, and their affinity towards the enzyme.
Alternatively, uncompetitive inhibition indicates the case in which an inhibitor
shows affinity to only the enzyme-substrate complex (ES). As such, the formation of
ES is a prerequisite for the inhibition. Upon binding to the ES complex, the
uncompetitive inhibitor prevents the subsequent transformation of the ES complex to
the bound transition state of the substrate (ES+). In uncompetitive inhibition, the
apparent Km and Vmax decrease as the concentration of the uncompetitive inhibitor
increases.
Lastly, a noncompetitive inhibitor exhibits affinity to both the free enzyme E and
the enzyme-substrate complex ES, resulting in the formation of the enzyme-inhibitor
(EI) and the enzyme-substrate-inhibitor (ESI) complexes. The dissociation constants
of EI and ESI are Ki and αKi, respectively. When α = 1, the noncompetitive inhibitor
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has equal affinity towards the free enzyme E and the ES complex. When α < 1, the
binding of the noncompetitive inhibitor towards the ES complex is more favorable
whereas with α > 1, the noncompetitive inhibitor shows stronger affinity to the free
enzyme.

Figure 1.4. Enzyme inhibition mechanisms
1.1.4. Enzyme Assays
Enzyme assays are the measurement of substrate depletion or product
formation for enzyme-catalyzed reactions to study the function of enzymes or quantify
enzymes. Performing these assays allows for either qualitative or quantitative analysis
of enzyme. Owing to enzyme’s highly selective catalysis, the presence of one enzyme
in an unknown sample can be confirmed by its catalyzed reaction. Meanwhile, for the
9

quantitative analysis of an enzyme, determining enzyme concentration is enabled by
measuring substrate depletion or product formation.
An assay is initiated by mixing substrates, cofactors and the enzyme, followed
by incubating the reaction mixture. In subsequence, the products or substrates can be
monitored continuously as the reaction proceeds (continuous assays) or after the
reaction is terminated (discontinuous assay). The incubation can be terminated by
adding a quenching reagent to the reaction mixture, rapid freezing or heating without
destroying the product. Acids such as perchloric acid and trichloroacetic acid are
usually added to denature the enzyme, and consequently quench the reaction. For
enzymes that require divalent metals as a cofactor, ethylenediaminetetraaceticc acid
(EDTA) can be added to form chelate with metal ions and stop the reaction [6].
One of the conventional methods used for enzyme assays is radiochemical
assay. This type of assay utilizes radiolabeled substrates containing radioactive
isotopes, typically

14C

or

32P,

which are then incorporated in the products as the

enzymatic reactions proceed. Radioactive isotopes are unstable, and they undergo
radioactive decay to release energy through particle emission (alpha particles, beta
particles) or electromagnetic radiation (gamma rays). In a radiochemical assay, after
the incubation is quenched, a scintillation solution containing a solvent and a phosphor
is added to the reaction mixture, followed by radioactivity measurement. Upon
interacting with a phosphor, the energy emitted by radioactive decay can be absorbed
by the phosphor which in turn emits light. This light emission, also known as
scintillation, can be measured by a liquid scintillation counter, which is equipped with
a photomultiplier tube. Depending on the stability of the products and substrates,
quenching reagents are added to selectively remove the less stable components.
Then either the remaining substrates or resulting products are measured by liquid
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scintillation counting. For example, Tanabe and coworkers reported on a
radiochemical assay for acetyl-coenzyme A carboxylase (ACC) where the substrate
KH14CO3 is less stable than the product [14C]malonyl-CoA. After HCl was added to the
incubation mixture, the unreacted KH14CO3 was removed, and the concentration of
the acid-stable [14C]malonyl-CoA was subsequently measured based on its
radioactivity [11]. Guchhait and coworkers demonstrated the carboxyltransferase
radioactive assay in which the substrate [14C]malonyl-CoA is acid-stable while the
product N-[14C]carboxybiotin methyl ester was destroyed upon the addition of HCl [12].
As a result, the enzyme activity was monitored based on the decrease in radioactivity
of the product after incubation. Despite its application to plethora of enzymes, the
radiochemical assay is limited in practice due to high cost, health risk, and issues
related to waste regulation.
Simple, direct spectrophotometric assays were also developed to study
enzyme kinetics and inhibition [13-15]. This type of assay is feasible if the difference
in signal of the substrates and products can be detected. For example, dipeptidyl
carboxypeptidase, an angiotensin converting enzyme (ACE), was assayed using the
direct spectrophotometric assays [14, 15]. This enzyme catalyzes the conversion of
angiotensin I (a decapeptide) to angiotensin II (an octapeptide) and a C-terminal HisLeu [14, 15]. Holmquist et al. used the artificial furanacryloyl-blocked tripeptides as
substrates for the dipeptidyl carboxypeptidase-catalyzed reaction [14]. A blue shift of
the absorption spectrum was observed owing to the hydrolysis of the substrates into
funranacryloyl-amino acids and dipeptides. The reaction progress was monitored
based on the decrease in absorbance of the reaction mixture at 328 and 352 nm [14].
Based on this assay, other spectrophotometric assays were modified and optimized
to study kinetics and inhibition of ACE [15, 16]. Similarly, Hayre et al. assayed sialidase
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using two artificial substrates [13]. The kinetic study was based on the red shift of
absorption spectrum from 300 to 315 nm upon the hydrolysis of the substrate. Despite
their applicability to various enzymes, direct spectrophotometric assays are limited to
enzymatic reactions which result in a change in the absorbance.
For enzymatic reactions whose substrates or products are difficulty to detect
directly, additional enzymes are often used for indirect monitoring of the reaction
progress. Such cases are referred to as coupled enzyme assays. In this type of assay,
either the product or substrate of the primary reaction becomes the substrate for the
coupling enzymatic reaction whose progress is easily monitored. The most common
coupling enzymes involve the oxidation of NAD(P)H or reduction of NAD(P)+ which
can be detected by UV-Vis absorption or fluorescence, typically carried out in cuvettes
or well plates. Coupled enzyme assays offer the advantages of both continuous and
discontinuous monitoring of reaction progress and applicability to high-throughput
screening (HTS). There are some practical guidelines that need to be considered
when carrying out coupled enzyme assays. First, the final signal should primarily
correspond to the activity of the enzyme of interest and be independent of the coupling
enzymes. This can be achieved by using relatively low concentration of the primary
enzyme compared to the coupling enzymes, so that the primary enzyme is ratelimiting. Second, the inhibition detected upon screening should be due to inhibition of
the primary enzyme, but not the coupling enzymes. As such, it is important to verify
that the coupling enzymes do not give false positive by carrying out a control
experiment with the coupling enzymes and in the absence of the primary enzyme.
Third, the signal recorded should correspond to the product formation or substrate
disappearance, and not be interfered with by the signal from the inhibitor or other
enzyme assay components. Subtracting the attributed signal of control (not containing
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the enzyme) from the final signal or using a proper detection method to selectively
measure the substrate or product will enable monitoring of reaction progress with
limited spectral interference. Fourth, for coupled enzyme assays, besides the reagents
required for the primary reaction, additional reagents including the coupling enzymes,
substrates and cofactors for the coupling reactions are also needed. Therefore,
coupled enzyme assays can be costly, especially for high-throughput screening, which
requires a large amount of reagents for a large library screening.
For reactions whose substrates and products cannot be quantified reliably
during the reaction, it is desirable to perform the assay after the reaction is quenched
and separate the assay mixture prior to analysis. Separation-based enzyme assays
have been implemented, using high performance liquid chromatography (HPLC) or
capillary electrophoresis (CE) [17, 18]. In such assays, the reaction should be stopped
within the initial phase where the signal is linearly proportional to reaction time (Figure
1.2). In subsequence, the enzyme components are separated and quantified based
on the area under their corresponding peaks. The typical detection methods used for
HPLC and CE include UV-vis absorption and fluorescence.
1.2. Acetyl-Coenzyme A Carboxylase (ACC)
1.2.1. Overview on ACC
Acetyl-coenzyme A carboxylase (ACC) is an essential enzyme for fatty acid
synthesis and metabolism [19]. Discovered by Wakil and Gibson 60 years ago, this
enzyme was recognized for containing a high biotin concentration and its involvement
in long-chain fatty acid synthesis from acetyl-CoA [20]. Between two enzymes required
for long-chain fatty acid synthesis from acetyl-CoA (ACC and fatty acid synthase),
ACC has lower catalytic capacity than fatty acid synthase [21]. This finding suggests
that ACC is responsible for the rate-limiting step in fatty acid synthesis.

13

ACC is a biotin-dependent carboxylase made up of three components including
biotin carboxylase (BC), carboxyltransferase (CT) and biotin carboxyl carrier protein
(BCCP). Biotin, also known as vitamin H or vitamin B8, is a prosthetic group covalently
attached to BCCP through an amide bond. ACC catalyzes the carboxylation of acetylcoenzyme A (acetyl-CoA) to generate malonyl-coenzyme A (malonyl-CoA) in two half
reactions (Figure 1.5). The first half-reaction, which is catalyzed by BC, involves the
carboxylation of biotin at the 1’-N position, forming the 1’-N-carboxybiotinyl derivative.
This half-reaction requires ATP, biotin, and bicarbonate as the substrates and Mg2+ as
the cofactor. The reaction between ATP and bicarbonate to form an activated
carboxyphosphate intermediate generates energy needed for the BC-catalyzed
reaction [21, 22]. Divalent cations such as Mg2+ or Mn2+ are required to stabilize ATP.
Meanwhile, bicarbonate is the source of carbonyl for the carboxylation reaction. The
second half-reaction of the ACC catalysis, which is catalyzed by CT, involves
transferring the carboxyl group from biotin to acetyl-CoA to form malonyl-CoA.
ACCs have been widely found in most living entities such as bacteria, viruses,
fungi, plants, animals, and humans. In bacteria, plants chloroplasts, and other
prokaryotes, ACCs are expressed as multi-subunits that readily dissociate [19]. In
contrast, in humans, cytosols of plants, and most of eukaryotes, ACCs have been
discovered in large multi-domains where BC, CT and BCCP are tightly incorporated in
a polypeptide chain [22].
In E. coli, ACC is a multi-subunit form consisting of three components. The BC
subunit is a 49.4 kDa protein made up of 449 amino acids and exists as a dimer in
solution [19, 23]. The BCCP component (156 residues, 16.7 kDa) exists as either a
dimer or higher oligomer [19, 23]. The CT component consists of α subunit (319
residues, 35.1 kDa) and β subunit (304 residues, 33.2 kDa), which form a stable α2β2-
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tetrameric complex [19, 23]. When in the same solution, the three components of ACC
form an unstable holoenzyme (holo-ACC) which dissociates into individual subunits.
Although the stoichiometry of the bacterial complex remains unknown, a complex of
BCCP with BC was isolated from E. coli, which comprises two BCCP molecules per
BC molecule [23]. Interestingly, in bacteria, either the BC or CT subunit can be isolated
separately and exhibit catalytic ability without the other two ACC components. The
reactions catalyzed by these two subunits make use of biotin or its derivatives as a
substrate [7]. Malonyl-CoA, one of the products in the ACC-catalyzed reaction, is the
building block for fatty acid biosynthesis. The bacteria use fatty acid for cell membrane
biogenesis. As a consequence, inhibition of ACC results in cell death in bacteria, which
suggests that ACC be a promising target for antibiotic drug development [24].
In humans and other mammals, the multi-domain ACCs have been identified in
two forms: ACC1 and ACC2 [25]. These two isoforms are different in distribution,
structure, and biological roles. ACC1, a 265 kDa protein consisting of 2346 amino acid
residues, is localized in cytosol of lipogenic tissues such as liver, adipose and lactating
mammary glands. Malonyl-CoA derived from the ACC1-catalyzed reaction provides
the essential building blocks for fatty acid elongation. In contrast, ACC2 is a larger
protein (280 kDa, 2483 amino acid residues), which is highly expressed in
mitochondria of oxidative tissues such as heart, skeletal muscles and sparingly in liver
[25]. While the two isoforms share about 70% amino acid sequence in common [25],
ACC2 has an extra 136 amino acids, 114 of which form the N-terminus that enables
ACC2 to target the outer mitochondria membrane [26]. In oxidative tissues, long chain
acyl CoAs requires conversion to acylcartinines in order to cross mitochondrial
membranes for fatty acid oxidation. This conversion is catalyzed by carnitine
palmitoyltransferase 1 (CPT-I). The malonyl-CoA product of the ACC2-catalyzed
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reaction is a potent allosteric inhibitor of CPT-I (IC50=1.5 µM) and hence stimulates
fatty acid oxidation in mitochondria [27].

Figure 1.5. ACC-catalyzed reaction
The active form of ACCs in humans and mammals is a linear polymer with the
molecular weight Mr of 4-8 million, and consists up to 20 protomers which are ACC
dimers [28]. Multiple factors such as diet, hormones, and other feedforward and
feedback regulators play an important role in regulating ACC activity. Particularly,
citrate and long-chain acyl-CoAs were identified as regulators of mammalian ACCs.
Citrate regulates these ACC isoforms through reversible phosphorylation and
allosteric activation, and ultimately induces polymerization of ACC protomers [29].
Locke and coworkers discovered that citrate enhances the activities of recombinant
human ACC1 and ACC2 by 1000-fold and 4-fold, respectively [30]. Interestingly,
citrate activates both types human ACCs at low concentrations but inhibits at high
concentration. Apparent Kd values (0.8±0.3 mM and 3.4±0.6 mM) and apparent Ki
values (20±8 mM and 38±8 mM) were reported for ACC1 and ACC2, respectively [30].
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The site of citrate action was previously reported to be on the BC domain where the
dimerization site is located. The activation mechanism of citrate was evaluated by
investigating the crystal structural of the phosphorylated BC domain of human ACC2
in presence of citrate [31]. In this structure, the phosphorylated Ser222 is known to
disrupt ACC polymerization by binding to the dimer interface of BC. Citrate is
responsible for removing the phosphorylated Ser222 from BC dimer interface;
therefore, citrate promotes polymerization and activates ACC [31]. In contrast, longchain acyl-CoAs are bound tightly to ACC, causing dissociation of ACC polymer into
protomers.
The significance of ACC2 as a target for drug discovery to treat metabolic
diseases was validated in ACC2-knockout mice [32, 33]. Compared to the wild type,
ACC2-knockout mice had malonyl-CoA levels in heart and muscle reduced by 10- and
30-fold, respectively. In addition, these mutant mice had fatty acid oxidation rate
accelerated by 30% and fat accumulation in adipose tissue decreased by 50% [32].
Even on high fat and high carbohydrate diets, compared to the wild type, ACC2 mutant
mice gained less weight, accumulated less fat, and maintained normal insulin and
glucose levels while the wild type exhibited type-2 diabetes [33]. Therefore, ACC2 is
an attractive target for drug development to treat obesity, type-2 diabetes as well as
other metabolic syndromes and associated diseases such as cardiovascular diseases,
atherosclerosis, and hepatic steatosis [19, 34-37].
Recent studies have suggested that ACCs are attractive targets for anticancer
therapy [38, 39]. Both isozymes are overexpressed in liver, lung, gastric, breast, and
prostate cancer cells whose survival and invasiveness rely on fatty acids [38-42]. The
use of small inhibitors of ACCs or RNA interference has proved to limit cancer cell
proliferation and induce apoptosis [40, 42, 43]. This is exemplified by the work of

17

Beckers et al. in which soraphen A, a potent inhibitor of human ACC2 (IC50 = 3 nM)
[44], was tested on prostate cancer cell lines [43]. It was reported that at nanomolar
concentrations, soraphen A reduced fatty acid synthesis and enhanced fatty acid
oxidation while causing limited formation of phospholipids in prostate cancer cells.
Relative to normal cells, cancer cells exhibited selectively suppressed proliferation and
induced cell death upon incubation with soraphen A. In another study, Sevensson et
al. reported that ND-646, an allosteric inhibitor of ACC1 and ACC2, significantly
reduced the growth of lung tumors [42]. In addition to small inhibitors of ACCs, the
impact of RNA interference on ACC genes in cancer cells was also investigated [40].
Chajes et al. reported that silencing of ACC by the RNA is associated with the
decrease of palmitic acid, which induced apoptosis in breast and prostate cancer cells.
This discovery is consistent with the previous findings that cancer cell survival and
invasive growth are strongly dependent on ACC activity.
Potent inhibitors of both ACC1 and ACC2 have been identified [44-46]. These
can be categorized into three groups based on their inhibition mechanism. The first
group is composed of long-chain fatty acid analogs which derive their efficacy through
competing with acetyl-CoA in the CT-catalyzed half-reaction. Examples of inhibitors in
this

group

include

haloxyfop,

sethoxydim,

and

TOFA

(5-(tetradecyloxy)-2-

furancarboxylic acid). The second group of ACC inhibitors is made up of
bipiperidylcarboxamides which are potent, reversible, and isozyme-nonselective
inhibitors of CT. For example, CP-610431 is a dual inhibitor of both ACC1 and ACC2
isozymes with IC50 (inhibitory concentration 50%) values of 50 nM [34]. Another
analog, CP-640186, exhibited inhibition against both isozymes with IC50’s of ~ 50 nM.
Inhibition study of ACCs by both compounds demonstrated lower malonyl-CoA
production, reduced fatty acid synthesis and stimulated fatty acid oxidation in cultured
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cells as well as experimental animals [34]. Harriman and coworkers identified ND-630
as a potent inhibitor of ACC1 and ACC2 with IC50 values of 2.1 nM and 6.1 nM,
respectively.

This

compound derives

its

efficacy by interacting

with

the

phosphopeptide acceptor and interrupting ACC polymerization via its interaction with
the dimerization site on the BC domain [37]. Cultured cells and animals treated with
ND-630 exhibited reduced fatty acid synthesis and elevated fatty acid oxidation. Upon
administration to the rats with diet-induced obesity, ND-630 was effective in enhancing
insulin sensitivity, reducing weight gain, and lowering hepatic steatosis. The third
group of ACC inhibitors includes polyketide natural product fungicides that inhibit ACC
by disrupting the dimerization on the BC domain. Among this group, soraphen A, a
compound isolated from Sorangium celulosum, has been reported as one of the most
potent human ACC inhibitors (ACC1 IC50 ~1-5 nM, ACC2 IC50 = 3 nM) [44].
1.2.2. Enzyme Assays of ACC
1.2.2.1. Assays for bacterial enzymes
There have been assays developed for not only holo-ACC, but also the BC and
CT subunits. While the holo-ACC assay required all three components (BC, CT, and
BCCP), either the BC or CT subunit exhibited catalytic activity without the other two
ACC components. The enzymatic reactions catalyzed by BC and CT usually utilize
biotin or its derivatives as a substrate. Various assays have been reported including
radioactive assays, spectrophotometric coupled assays, and separation-based
assays. The radioactive assays utilize radiolabeled reagents and are based on
measuring the radioactivity of the product formed or substrate depleted. The coupled
assays require coupling reactions that involve the oxidation of NAD(P)H or reduction
of NAD(P)+ cofactors, followed by spectrophotometric detection at 340 nm. Recently,
separation-based assays have been developed for ACC, BC, and CT, based on the
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separation of reactants and substrates in prior to UV-Vis, fluorescence or mass
spectrometry detection.
1.2.2.1.1. BC enzyme assays
The BC subunit catalyzes the ADP-dependent reaction in which the carboxyl
group is transferred from the bicarbonate to biotin. The BC assays utilized ATP, Mg2+,
KHCO3, and free biotin as the substrates. As the reaction proceeds, the products
including ADP, the carboxylated biotin, and PO43- were generated.
One of the earliest assays developed to study the BC subunit was based on the
-

incorporation of H14CO3 into 1’-N-[14C] carboxybiotin, which was often referred to as
the

14C

bicarbonate fixation assay [12]. In this assay, the radio-labeled bicarbonate

substrate H14CO3-, which is also the source of carboxyl group for the ACC-catalyzed
reaction, was incubated with other reagents including ATP, Mg2+, biotin, and BC. The
reaction was terminated the addition of ice-cold water and 1-octanol. Carbon dioxide
bubbles were pumped through the reaction solution to remove the unreacted H14CO3. The resultant solution contained [14C] carboxybiotin product whose radioactivity was
measured using a liquid scintillator spectrometer.
Coupled enzyme assays have also been developed to eliminate the use of
radioactivity. Eventually, the reactants and products in ACC-catalyzed reaction
including ADP, ATP, acetyl-CoA, and malonyl-CoA all strongly absorb in the UV range
at similar wavelengths. As a consequence, it is very difficult to detect one single
component among others. Coupling the ACC-catalyzed reaction with secondary ones
allows for indirect monitoring of reactant depletion or product formation. This concept
was exemplified by the detection of ADP product when pyruvate kinase and lactate
dehydrogenase were used as coupling enzymes, as presented in Scheme 1.1:
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Pyruvate kinase

ADP + phosph(enol)pyruvate ⎯⎯⎯⎯⎯⎯⎯⎯⎯ ATP + Pyruvate
Lactate Dehydrogenase

pyruvate + NADH ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯

+

Lactate + NAD

Scheme 1.1. Coupling reactions catalyzed by pyruvate kinase and lactate
dehydrogenase
This coupled assay has been applied widely to study the forward reaction
catalyzed by BC [12, 47, 48]. In this assay, the ADP product of ACC-catalyzed reaction
becomes a reactant in the pyruvate kinase-catalyzed reaction where it reacts with
phosph(enol)pyruvate to form ATP and pyruvate. In the subsequent reaction catalyzed
by lactate dehydrogenase, pyruvate oxidizes NADH to produce lactate and NAD. As
a result, the presence of ADP is accompanied with the depletion of NADH which is
indicated by the decrease in absorbance at 334 nm or fluorescence at 460 nm.
1.2.2.1.2. CT enzyme assays
Similar to the BC subunit, the CT subunit also has catalytic activity as a
standalone enzyme. CT catalyzes the transfer of the carboxyl group from biotin to
acetyl-CoA to form malonyl-CoA. However, in practice, the CT-catalyzed reaction has
frequently been monitored in the reverse, non-physiological direction (malonyl-CoA
reacts to from acetyl-CoA). Biocytin or biotin methyl ester (BME), biotin analogs of
higher reactivity (with maximal velocity Vmax of 3 orders of magnitude higher than
biotin) have been used as carboxyl acceptors for the reverse direction of the CT
reaction [12, 24, 49, 50].
A radioactive assay for the CT subunit involves the use of [3-14C-] or [214C]malonyl-CoA

and d-biotin methyl ester [12, 51]. The reaction was quenched by

HCl, and the reaction mixture was then dried in the oven, followed by the addition of
water and scintillator. Subsequently, the [2-14C]acetyl-CoA, [14C]O2, and [14C]carboxyl
group in N-carboxybiotin methyl ester were all removed from the resultant mixture due
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to their high volatility whereas the heat- and acid-stable [14C]malonyl-CoA remained.
The enzyme activity of CT is then calculated based on the decrease in radioactivity of
[14C]malonyl-CoA after the reaction completes.
In addition, another coupled assay using citrate synthase and malate
dehydrogenase was reported by Guchhait et al. for the reverse direction of the halfreaction catalyzed by CT [12], as presented in Scheme 1.2:
malonyl-CoA + d-biotin methyl ester
CT

acetyl-CoA + 1'-N-carboxy-d-biotin methyl ester
citrate synthase

acetyl-CoA + oxaloacetate + H2O ⎯⎯⎯⎯⎯⎯⎯⎯⎯
malate + NAD

+ malate dehydrogenase

⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯

citrate + CoA-SH

oxaloacetate + NADH + H

+

Scheme 1.2. Coupling reactions catalyzed by citrate synthase and malate
dehydrogenase to study CT.
The activity of the enzyme was measured for the reverse direction of the CTcatalyzed reaction in which malonyl-CoA reacts with d-biotin methyl ester (an analog
of biotin) to produce acetyl-CoA. Citrate synthase subsequently catalyzes coupling
reaction where acetyl-CoA reacts with oxaloacetate to form citrate and free coenzyme
A (CoA-SH). Oxaloacetate is also the product of the second coupling reaction between
malate and NAD+, catalyzed by malate dehydrogenase. The other product of this
reaction, NADH, is detected spectrophotometrically at 340 nm. This coupled assay
was applied to kinetic and inhibition study of CT in E.coli [12, 48, 50, 52, 53].
Another coupled assay utilizing malonyl-CoA reductase (MCR) was applied to
study the CT unit via detection of malonyl-CoA [54], as presented in Scheme 1.3:
+ MCR

malonyl-CoA + NADPH + H

+

⎯ malonic semialdehyde + NADP + CoA

22

+ MCR

malonic semialdehyde + NADPH + H

+

⎯ 3-hydroxypropionate + NADP

Scheme 1.3. Coupling reactions catalyzed by malonyl-CoA reductase to study CT.
The coupling enzyme MCR isolated from E. coli catalyzes the reduction of
malonyl-CoA to 3-hydroxypropionate via the two-step reactions that require two
NADPH molecules. The decrease in NADPH concentration was monitored
spectrophotometrically at 365 nm (ϵ365 nm, 2NADPH = 6.8 × 103 M-1 cm-1). This coupled
assay was applied to assay ACCs isolated from Metallosphaera sedula [54].
Similarly, a coupled assay was developed by Santoro et al. and applied to study
the CT subunit [24]:
malonyl-CoA + biocytin

CT

acetyl-CoA + carboxybiotin
citrate synthase

acetyl-CoA + oxaloacetate + H2O ⎯⎯⎯⎯⎯⎯⎯⎯⎯

citrate + CoA-SH

CoA-SH + DTNB → TNB + CoA-S-S-TNB
Scheme 1.4. Coupling reaction catalyzed by citrate synthase
Similar to the assay developed by Guchhait et al., the assay presented in
Scheme 1.4 is applicable to the reverse direction of CT-catalyzed reaction, but using
biocytin as the carboxyl receptor instead of d-biotin methyl ester. It also involves the
conversion of acetyl-CoA and oxaloacetate to citrate and CoA-SH in the presence of
citrate synthase. A second coupling enzyme malate dehydrogenase was omitted and
5,5’-dithiobis(2-nitrobenzoic acid) (DTNB, Ellman’s reagent) was used instead to
detect CoA-SH. The yellow product, thionitrobenzoate (TNB) absorbs in the visible
range and is measurable at 412 nm. This coupled assay was performed with C.
glutamicum, a gram positive bacterium, validated in an inhibition study of a known CT
inhibitor, and further tested as a high-throughput assay for CT in E.coli [24, 55].
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Recently, CE-based assays were developed and applied to study inhibition of
CT [49, 52]. In these assays, acetyl-CoA and malonyl-CoA were separated based on
their electrophoretic mobility and detected using UV-Vis absorption. Meades et al.
successfully applied the CE assay to testing inhibition of E. coli CT by 1,4-hydroxy-3methoxy-trans-cinnamaldehyde, an abundant compound in cinnamon bark extract
[52].
1.2.2.1.3. Holo-ACC enzyme assays
Holo-ACC assays were adapted from either the BC or CT assays [47, 48, 51,
56]. One of the most common assays used for kinetics and inhibition studies of holoACC is the coupled assay in which pyruvate kinase and lactate dehydrogenase are
used as the coupling enzymes [47, 56]. Alternatively, holo-ACC has been assayed by
-

the incorporation of 14CO2 from H14CO3 into the acid-stable product malonyl-CoA [48,
51].
Recently, a capillary electrophoresis-based assay for E.coli ACC was
developed by Bryant and coworkers [49]. This assay involved the separation of
substrates and products including ADP, ATP, acetyl-CoA, and malonyl-CoA, followed
by UV-Vis detection at 256 nm without the need of either the coupling enzymes or
radiolabeled reagents.
1.2.2.2. Mammalian ACC assays
Mammalian ACCs exist in two isoforms: ACC1 and ACC2. Both the isozymes
require citrate as an enzyme activator. Therefore, in mammalian ACC assays, in
addition to all reagents needed for the bacterial assay, citrate must be added to the
reaction mixture.
Radiochemical assays of ACC have been adapted from the assays which were
previously developed for bacterial ACCs. The commonly used radiochemical assays
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were based on the 14C fixation [11, 57-60]. Another radiochemical assay for ACC, but
less common than the 14C fixation assay, is based on the measurement of [32P]Pi [29].
In such an assay, the radioactive [γ-32P] ATP substrate was consumed while the
[32P]Pi product, a high-energy beta emitter, was generated, extracted by liquid-liquid
extraction, then measured by the Cherenkov effect [29].
Coupled enzyme assays have been widely used to study kinetics and inhibition
of human and mammalian ACCs [11, 29, 30, 61-63]. The most common coupled
assays are based on the detection of ADP using pyruvate kinase and lactate
dehydrogenase as the coupling enzymes [11, 29, 30]. Alternatively, other coupled
assays which are based on indirect detection of malonyl-CoA [63] and inorganic
phosphate [61, 62] were developed to study human and mammalian ACCs. In
addition, Hashimoto et al also developed a coupled assay in which hexokinase and
glucose-6-phosphate dehydrogenase (G6PD) are used as the coupling enzymes for
indirect detection of ATP [29]:
hexokinase

ATP + glucose ⎯⎯⎯⎯⎯⎯
G6P + NADP

+ G6PD

⎯⎯

ADP + G6P

6-phospho-glucono-1,5-lactone + NADPH + H

+

Scheme 1.5. Coupling reactions catalyzed by hexokinase and glucose-6-phosphate
dehydrogenase.
The assay presented in Scheme 1.5 was based on the conversion of ATP and
glucose to ADP and G6P with hexokinase, followed by the reduction of NADP+ to its
reduced form (NADPH) which was measurable by either UV absorption at 340 nm or
fluorescence at 460 nm. This assay was applied to kinetic study of ACC isolated from
rat liver [29].
Separation-based assays have been developed for mammalian ACCs.
Spiegeleer et al. reported a direct assay for ACC based on HPLC separation of short-
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chain CoAs including acetyl-CoA and malonyl-CoA, followed by absorbance
measurement at 258 nm [64]. Similarly, Kim and coworkers described the HPLC assay
to study kinetics of recombinant human ACC2 [65]. This assay allowed the separation
and quantification of both acetyl-CoA and malonyl-CoA. However, both the substrate
([1-14C]acetyl-CoA) and its corresponding product ([2-14C]malonyl-CoA) were
radioactive and detected by the radiometric detector. Alternatively, Kaushik and
coworkers characterized recombinant human ACC2 kinetics using LC/MS/MS which
offered sensitive detection of malonyl-CoA [66]. The need of the stable isotope labelled
reagent ([3-13C]malonyl-CoA) as an internal standard is a drawback of this assay.
1.3. Capillary Electrophoretic Enzyme Assays
1.3.1. Capillary Electrophoresis
Capillary electrophoresis (CE) is a separation technique used to separate small
molecules as well as biological macromolecules such as DNA, proteins, and
nucleotides. Characteristic advantages of CE include low sample consumption (nL),
high separation efficiency, simple alteration of separation mechanisms, a wide variety
of detection methods, short analysis time, and possibility of automation. The modes of
CE separation that have been developed include capillary zone electrophoresis (CZE),
capillary electrochromatography (CEC), micellar electrokinetic chromatography
(MEKC), capillary isoelectric focusing (CIEF), capillary gel electrophoresis (CGE), and
capillary isotachophoresis (CITP). Among these, CZE is the simplest and most
commonly used form of CE. In 1981, Jorgenson and Lukacs were first to report CZE
separation of derivatized amino acids, dipeptides, and amines with high efficiency
using glass capillaries and fluorescence detection [67]. In 1991, Banke and coworkers
pioneered using capillary electrophoresis to perform enzyme assay of alkaline
protease [68]. Since then, CE-based enzyme assays have been developed to study
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enzyme kinetics, enzyme inhibition, and screen for enzyme inhibitors [18].The number
of publications on CE over the period from 1981 through 2018 is summarized in Figure
1.6.

Growth of CE literature (1981-2018)
3000
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2020

Figure 1.6. The growth of CE publications from 1981 to 2018. The Web of Science
database was searched using the keyword “capillary electrophoresis”.
A typical CE system is illustrated in Figure 1.7 and includes a capillary, high
voltage power supply, two buffer reservoirs, two electrodes and a detector. The
capillary used in CE is typically made from fused-silica, with an inner diameter from 20
to 100 µm and an outer diameter of 150-360 µm. The outside of the capillary is coated
with a protective layer (polyimide) to enhance its durability. A small portion of this
coating is burned to create a detection window which is located near the capillary
outlet. Both ends of the capillary and two electrodes connected to a high voltage power
supply are immersed in two buffer vials.
At the beginning of a CE separation procedure, the capillary is usually
conditioned by rinsing with a strong base such as NaOH to increase the negatively
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charged silanol groups on the capillary inner surface. As the capillary is filled with
buffer, the cations in buffer are attracted to the capillary wall, creating electrical double
layer (Figure 1.8). The layer closest to the wall is referred to as Stern layer while the
diffuse layer further away from the wall is called the Gouy layer. The cations making
up the latter are mostly solvated cations which move towards the cathode under the
applied voltage, dragging along the bulk solvent, creating electroosmotic flow (EOF).
The EOF is calculated as follows:



 eof  4 E

1.8

where  eof is the electroosmotic velocity,  is the dielectric constant, ζ is the
zeta potential measured at capillary-buffer interface, E is the electric field, and  is the
viscosity of the buffer.
Data acquisition
4.0
Mg-ATP

B

3.5

Absorbance (mAU)

3.0
2.5

Acetyl-CoA

2.0
1.5

*

1.0

Malonyl-CoA

Mg-ADP
0.5

DMSO

0.0
-0.5

Detector

1.0

Capillary
Anode

Cathode

Electroosmotic flow

-

+
Inlet Sample
buffer

Outlet
buffer

+

-

High voltage
power supply

Figure 1.7. Scheme of a basic capillary electrophoresis system
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The electroosmotic mobility is then calculated as:

 eof   Eeof





1.9

4

The EOF is important for electrokinetic separation in CZE since it acts as a
pump to move all species regardless of their charge (cations, anions, neutral
compounds) towards the capillary outlet. The magnitude of the EOF depends on the
concentration of electrolytes and pH of the buffer solution. Since zeta potential is
reversely proportional to the square root of the electrolyte concentration, increasing
the electrolyte concentration decreases the zeta potential, and subsequently
decreases the EOF. In a fused silica capillary, electroosmotic flow is reduced in buffer
solution of low pH (<7.0) due to the conversion of SiO- back to SiOH. In practice, EOF
is measured based on the migration time of a neutral solute such as methanol, mesityl
oxide, and DMSO. While EOF is desired for most CZE and MEKC separations, it is
actively suppressed to perform IEF or ITP techniques. The EOF suppression is
enabled by using Teflon capillary, properly coated capillary, or adding additives to the
buffer solution.
In addition to the EOF, a more important factor affecting the migration in CZE
is the electrophoresis which directs cations towards the cathode, anions towards the
anode while the neutral analytes are not affected by the electric field. The rate at which
the analytes migrate in the capillary under electric field, also referred to as
electrophoretic velocity  ep , depends on the hydrodynamic size and charge of the
species and is calculated as follows:
q

V

 ep  f E   epE   ep Lt
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1.10

where

 ep is

the electrophoretic velocity, q is the effective charge of the

 ep is the electrophoretic mobility of the analyte,

analyte, f is the friction coefficient,

E is the electric field strength, V is the applied voltage, and Lt is the total length of the
capillary.
The friction coefficient (f) depends on the hydrodynamic radius of the solute (r)
and viscosity of the separation buffer:
f  6 r

1.11

Because the friction coefficient is directly proportional to the hydrodynamic
radius of the solute, the electropherotic velocity is inversely proportional to the size of

 ep is

the solute. A solute’s electrophoretic mobility

also proportional to the

electrophoretic velocity.
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Figure 1.8. Scheme depiction of the EOF formation inside the capillary
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Figure 1.9. The order of migration under EOF and electrophoresis
Figure 1.9 summarizes the migration order of analytes in the capillary in the
presence of both EOF and electrophoresis. The rate and direction of migration are
governed by electrophoresis and EOF. The apparent mobility of the solute

 app is a

vector sum of the electroosmotic mobility of the buffer solution and the electrophoretic
mobility of the solute.

 app   eof   ep
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When EOF is high relative to the electrophoresis, the cations migrate the fastest
towards the cathode, followed by neutral molecules and anions. The migration time tm
is the time it takes for a solute to migrate from the capillary inlet to the detection
window, which is also referred to as the effective length Ld.
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The development of MEKC has enabled the CE separations of charged and
neutral solutes through the use of micelles in the separation buffer [69]. Micelles are
aggregates of surfactants such as SDS, CTAB, which have a hydrophilic head and a
hydrophobic tail. The hydrophilic head can be cationic, anionic, zwitterionic, or
nonionic while the hydrophobic tail is normally a chain of hydrocarbon. In aqueous
solution, the hydrophilic heads interact with the surround solvent whereas the
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hydrophobic tails cluster towards the center of the micelle. Above the critical micellar
concentration (CMC), the micelles are fully formed. In CE separation, the micelles in
the separation buffer act as the pseudo stationary phase similar to the stationary
phase in reverse-phase HPLC. The separation in MEKC is based on the partition of
solutes between the micelles and buffer solution, which can be controlled by the ionic
strength, pH, temperature, and other additives in the separation buffer.
Depending on the properties of the analytes, CE can be coupled to different
detection methods such as ultraviolet-visible (UV-Vis) absorption, fluorescence (FD),
mass spectrometry (MS), or conductivity. Among these methods, UV-Vis absorption
is the most commonly used due to a wide range of organic molecules absorbing in the
UV-Vis region. However, high limits of detection (LOD) are a drawback for CE coupled
with UV-Vis absorption detection due to narrow bore, and, thus, short optical path
length provided by the capillary. This issue has been addressed by utilizing different
detection cells such as bubble cell capillary or Z-cell capillary to increase the path
length [70]. The limited optical path length is of less concern when using fluorescence
detection. The laser, which is a high intensity, highly collimated, monochromatic and
coherent light source, has been used widely as the excitation source for fluorescence
detection in CE. Laser-induced fluorescence (LIF) is the second most common
detection mode yet the lowest LOD for CE. [71]. In some cases, detection of a few to
single molecules was possible with CE and LIF [72, 73].
Recently, light-emitting diodes (LEDs) have been used as an alternative to
lasers as the excitation source for fluorescence detection in CE [74, 75]. A LED is a
semiconductor device that emits light when an electric current flows through it. Most
semiconductors are doped with impurities to add extra negatively charged electrons
(n-type) or positively charged holes (p-type). An LED is made up of n-type and p-type
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materials which are fused together and connected to electrodes on one end. Without
the applied voltage to the diode, holes from the p-type material are filled by electrons
from the n-type material, forming a depletion zone. When connecting the n-type
material is to the negative end and the p-type material to the positive end of the electric
circuit, the electrons from the n-type material move to the p-type material and the holes
move in the opposite direction. The recombination of electron-hole generates energy
in terms of photons. This effect is referred to as electroluminescence, and the
wavelength of the emitted light depends on the energy band gap between the
conduction band and the valence band of the semiconductor. The light beams emitted
by the LEDs are multichromatic with broad bandwidth (20-30 nm full width at half
maximum), noncoherent, and noncollimated. Lasers are monochromatic, coherent,
and collimated. The associated small size, low cost, low energy consumption, long
lifetime, and high stability make LEDs promising as light sources for fluorescence
detection.
Capillary electrophoretic enzyme assays can be categorized based on two
basic criteria. First, depending on where enzymatic reactions occur, enzyme assays
are classified as offline and online assays. All steps involved in an online assay take
place inside the capillary. However, in an offline assay, the incubation of reaction
mixture is carried out outside the capillary prior to the subsequent in-capillary steps.
Second, enzyme assays are either homogeneous or heterogeneous based on
physical states of the substrates and enzyme in an assay. When all reagents needed
for the assays including substrate, free enzyme, and cofactors are in solution, the
assay is heterogeneous. However, when the enzyme is immobilized onto the capillary,
within a sol-gel matrix, or onto a solid carrier while other assay components remain in
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solution, the assay is referred to as heterogeneous. These two criteria are usually
combined to specifically describe an enzyme assay.
Compared to traditional enzyme assays, CE-based assays have several
advantages to offer. First, as a separation technique, CE is capable of separating and
quantifying enzyme components including substrates, products, and inhibitors.
Therefore, CE-based assays are not susceptible to spectral interference as the
conventional plate reader- or cuvette-based assays. Second, relative to coupled
enzyme assays, CE enzyme assays are simpler and free of inhibitor interference.
Coupled enzyme reactions typically require coupling reactions which might be
interfered with by the inhibitor to give false positive results for inhibition measurement.
The majority of CE-based assays do not require coupling reactions, thus, inhibitor
interference is not a problem. Third, CE assays require smaller sample amounts (nL)
compare to plate reader- and cuvette-based coupled assays (µL-mL).
1.3.2. Offline Enzyme Assays
CE offline enzyme assay is the simplest CE-based assay. Offline enzyme
assays have been developed to study enzyme activity, kinetics, and inhibition [18, 76].
In offline assays, the reaction mixture is incubated for a certain time, typically in a vial.
After incubation, the resultant mixture is injected into the capillary, followed by
separation by CE. Figure 1.10 illustrates typical separations for an offline CE assay.
As the reaction proceeds, the substrate depletion and product formation can be
quantified using the corresponding peak areas. At the same time, the separation and
quantification of substrates and products makes CE-based assay less prone to
spectral interference compared to the conventional cuvette- or plate reader-based
assays.

34

Product

Substrate
20 min incubation

B

10 min incubation

A

0 min incubation

Signal

C

Time

Figure 1.10. Schematic depiction of the progress of substrate depletion and product
formation in an offline CE-based assay.
Banke and coworkers performed the first CE-based enzyme assay of an
alkaline protease [68]. In this study, CE was used to separate the fermentation broth
from Aspergillius oryzae, followed by collecting fractions of different peaks for further
characterization. One of the fractions was then incubated with Suc-Ala-Ala-Pro-Phep-nitroanilide, and the reaction mixture was separated by CE. The formation of a
proteolytic product p-nitroanilide suggested that the collected fraction contained an
alkaline protease. The identity of the enzyme was specified by incubating the same
fraction with casein, and a product peak was recorded by CE separation, indicating
that the enzyme catalyzed hydrolysis of casein. The two CE-based assays confirmed
that an endoprotease was present in the collected fraction. Since its first application
to study enzyme, CE has been widely used to develop offline enzyme assays [18].
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Figure 1.11. Schematic depiction of the separation of assay components with and
without an inhibitor.
In enzyme inhibition studies, the inhibitor is added to the reaction mixture which
contains the substrate, enzyme, and other cofactors. Figure 1.11 illustrates the CE
separations for enzyme inhibition studies. Less product is formed in the inhibited
reaction when compared to the control (without inhibitor). Also, the inhibitor can be
observed as an extra peak, provided that it gives response to the detector used. This
is an advantage of CE assay compared to the coupled enzyme assay. First, the
separation of all assay components including the inhibitor prior to detection makes the
CE less prone to spectral interference than the spectrophotometric coupled enzyme
assay. Second, most CE assays do not require coupling enzymes, so false positive
due to the compound inhibiting the coupling enzymes is not a concern. The
applicability of CE assay to study enzyme inhibition is exemplified by the CE-based
assay developed by Malina et al [77]. This was the study of phosphofructokinase-1
(PFK-1), which catalyzes the reaction of fructose 6-phosphate and ATP to form
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fructose 1,6-biphosphate and ADP. In this CE assay, the ATP and ADP were
separated and quantified at different incubation times to generate a reaction progress
curve. The assay was then applied to determine the half maximum inhibitory
concentration (IC50) of aurintricarboxylic acid (ATA), a known inhibitor of PFK-1. This
demonstrates that CE is suitable for qualitative and quantitative study of enzyme
activity and enzyme inhibition.
1.3.3. Online Enzyme Assays
In an online or in-capillary enzyme assay, all assay steps such as mixing,
incubation, and separation take place inside the capillary. Online assays are divided
into homogeneous and heterogeneous assays, depending on the physical phase of
the enzymes. A homogeneous online enzyme assay is typically referred to as
electrophoretically mediated microanalysis (EMMA). The first EMMA assay, which was
introduced in 1992 by Bao and Regnier, involved the study of glucose-6-phosphate
dehydrogenase, and relied on the difference in electrophoretic motilities of the
substrates, enzyme, and cofactors [78]. These components were injected in
consecutive plugs and mixed in the capillary by either diffusion or under applied
voltage. Alternatively, heterogeneous enzyme assays have been developed using
three approaches, with enzymes immobilized on either the inner capillary wall,
incorporated into a polymeric membrane or immobilized onto magnetic beads [79]. As
a result, in heterogeneous assays, enzymes are fixed inside the capillary, forming
immobilized enzyme microreactors (IMERs). Online enzyme assays offer some
advantages relative to offline assays. First, all steps involved in online assays are
carried out inside the capillary, which makes automation and miniaturization of the
whole procedure easier. Second, the amount of reagents required is lower for online
assay compared to offline approach. Consequently, online enzyme assays are
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promising methods applicable for routine and high throughput screening in
pharmaceutical studies and biochemical tests [80].
1.3.4. Electrophoretically Mediated Microanalysis
Electrophoretically mediated microanalysis (EMMA) is a homogeneous online
assay in which all the involved steps including sample introduction, incubation, and
separation take place inside the capillary. EMMA has been applied to study enzyme
kinetics and inhibition [18, 80-83]. Compared to offline CE assays, EMMA-based
assays offer significant advantages. First, only minute amount of reagents (nanoliter
scale) is needed for EMMA because incubation proceeds inside the capillary. In
addition, the automated procedure makes EMMA-based assays robust and applicable
to analyzing multiple samples with less labor in comparison to offline assays.
Depending on the way the sample is introduced to the capillary, EMMA can be
further categorized as either continuous engagement mode or transient engagement
mode [81]. In the continuous engagement mode, also known as the long contact
mode, the capillary is filled with a reagent, which often contains the buffer and the
substrate. In the subsequent steps, the enzyme is introduced into the capillary and
continuously mixes with the substrate as it migrates towards the capillary outlet under
applied voltage. This process leads to continuous formation and separation of product.
Other continuous EMMA assays were also developed in which the capillary was filled
with enzyme in prior to substrate injection [84].
Regarding the introduction of sample to the capillary, EMMA can be operated
in two ways: zonal injection or moving boundary. In zonal injection mode, the capillary
is first filled with buffer solution prior to a brief enzyme injection as a plug. When the
potential is applied across the capillary, the substrate contained in the inlet buffer
reservoir migrates through the capillary, reacts with the enzyme and generate
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products. On the other hand, moving boundary mode involves filling the capillary with
the reagent of lower electrophoretic mobility, then electrokinetically injecting the
reagent of higher electrophoretic mobility from the anodic buffer reservoir. As such,
the two reagents are mixed when migrating under the applied potential, resulting in
continuous product formation. Harmon et al. demonstrated the assay of leucine
aminopeptidase (LAP) using moving boundary EMMA [84]. The substrate of the LAPcatalyzed reaction, L-leucine-p-nitroanilide, has higher electrophoretic mobility than
the enzyme and was kept in the buffer reservoir at the capillary inlet. Meanwhile, the
capillary was initially filled with LAP enzyme. Following the application of voltage, the
substrate moved through the capillary full of enzyme and generated the product, pnitroaniline.
Depending on how the reagents are incubated, continuous engagement assays
can be further sub-categorized as either constant or zero potential. Bao et al.
described the enzyme assays of glucose-6-phosphate dehydrogenase using both
approaches [78]. Under constant potential throughout the separation, the product
formed is detected as a flat plateau. Sensitivity of this mode is inversely proportional
to the potential. At lower potential, the assay reagents migrate more slowly through
the capillary, which leads longer incubation and higher product formation yield.
Alternatively, in zero potential mode, after enzyme electrophoreses part way through
the capillary, the applied potential is reduced to zero for a few minutes before returning
to the original potential. This mode allows for longer incubation of the substrate and
the enzyme, resulting in additional accumulated product and enhanced sensitivity. The
corresponding electropherogram has a peak on top of a plateau. In another study, Xie
et al. reported the measurement of NAD+ and NADH in a single cell using EMMA in
the zero potential mode [85]. The scheme of the recycling assay is illustrated in Figure
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1.12. This is an enzymatic recycling assay that utilizes lactate dehydrogenase (LDH)
and diaphorase (DIA) to generate a fluorescent product, resorufin, as an indicator of
NAD+ and NADH present. For the EMMA-based recycling assay, the capillary was
initially filled with the Tris buffer solution containing lactate, resazurin, LDH and DIA.
The sample containing NAD+ and NADH was then introduced to the capillary and
separated for 3 min into two bands. Subsequently, the applied voltage was stopped
for up to 5 min for incubation. During this period, the enzymatic reactions took place,
producing two plugs of resorufin corresponding to NAD+ and NADH. Once the voltage
was applied again, the plugs of resorufin migrated towards the capillary end and were
detected using fluorescence detection. The recycling enzymatic assay offers sensitive
detection of NAD+ and NADH with the detection limits of 0.2 amol and 1.0 amol,
respectively.
Lactate dehydrogenase (LDH)
lactate

pyruvate

NADH

NAD+

resorufin

resazurin
Diaphorase (DIA)

Figure 1.12. Enzymatic recycling reaction for the detection of NAD+ and NADH.
The transient engagement format, also referred to as plug-plug mode, is an
alternative to continuous engagement EMMA. In this mode, the capillary is initially
filled with the buffer, followed by injecting the enzyme and substrate in separate small
plugs in order of increasing electrophoretic mobilities. Once the electric field is applied,
the plug of higher mobility faster than the plug of lower mobility towards the capillary
outlet, causing the plugs to overlap and products to be generated. Relative to the
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continuous engagement mode, the transient engagement mode consumes less
reagents, and is the most cost-effective.
1.3.5. Immobilized-Enzyme Microreactors
In heterogeneous enzyme assays, the enzymes are immobilized onto insoluble
supports through covalent bonds, ionic interaction, adsorption, entrapment, or crosslinking to form immobilized enzyme microreactors (IMERs) [82]. IMER-based assays
are promising for pharmaceutical, bioanalytical studies and industrial applications
thanks to the advantages they have to offer. First, properly immobilizing an enzyme
leads to stabilizing its conformation and makes it less prone to denaturation by heat,
extreme pH, or organic solvent. As such, immobilized enzymes are more stable
compared to free enzyme solution although the reduction in enzyme activity is often
reported [86, 87]. Second, unlike free enzymes, IMERs can be separated from the
incubation mixture and used repeatedly. Third, it is possible to have the enzyme
immobilized inside a capillary, reaction mixture incubated and assay reagents
separated, all in one capillary. Collectively, IMERs are applicable for miniaturized,
automated and cost-efficient enzyme assays.
IMERs have been fabricated using three main approaches. First, the enzyme
is directly immobilized onto the capillary inner surface, creating open tubular capillary
IMERs. CE-integrated open tubular IMERs are the simplest type of heterogeneous
online assays owing to their easy fabrication [86]. In such assays, the enzymes are
immobilized on the inner surface of the capillary through covalent bonds with silica or
electrostatic immobilization. Low loading capacity and enzymatic catalysis efficiency
are major drawbacks of open tubular IMERs owing to limited substrate-enzyme
contact area. Second, the enzyme can be encapsulated within a porous polymer
network inside the capillary to form monolithic IMERs. Compared to open tubular
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IMERs, monolithic IMERs provide enhanced surface-to-volume ratio. However, timeconsuming fabrication and the inability to remove IMERs from the capillary are limiting
factors to applicability of monolithic IMERs. Third, the enzyme can be immobilized onto
insoluble supports such as particles or membranes which are injected to and kept in
place inside the capillary. Such fabrications are referred to as packed IMERs. The
most popular case of packed IMERs involves the use of magnetic beads (MBs) which
can be manipulated by an external magnetic field and easily removed from the
capillary under high pressure or in the absence of magnetic field. In addition, the
surface to volume ratio for MB-based IMERs is also higher than that of open tubular
IMERs.
In conventional packed IMERs, the enzyme-immobilized particles are packed
inside the capillary using frits. This inflexible design makes it difficult to replace IMERs.
Recently, magnetic beads have emerged as the solid support for IMERs due to their
commercial availability, the ease of manipulating the beads inside the capillary using
external magnets and plethora of options of size (nanometer to micrometer scale) and
functional groups. Basic composition of a magnetic bead used for IMERs is illustrated
in Figure 1.13.
Fe3O4

Polymer/silica

Functional group

Figure 1.13. Composition of a typical magnetic bead
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A magnetic bead has the core made from superparamagnetic iron oxide Fe3O4
that is attracted to the magnetic field. The core is covered with a shell of polymer or
silica, which plays two important roles. First, the coating acts as the stabilizing material
that prevents the Fe3O4 particles from aggregation, thus retaining paramagetic
properties. Second, owing to the polymer coating, the surface of the magnetic beads
can be functionalized with ligands such as epoxy, carboxylic acid, streptavidin, and
antibody. The diversity of functionalized MBs enables the immobilization of various
biomolecules including proteins, enzymes, antigens, nucleic acids and mRNA.
Consequently, magnetic beads have been widely applied in life sciences,
biotechnology, and healthcare [18, 86].
The first CE assays using magnetic bead-based IMERs (MB-IMERs) on a
commercial CE instrument were developed by Rashkovetsky et al. [88]. This study
made use of two round rare earth colbalt magnets that were placed directly on the
capillary. In the alkaline phosphatase (AP) assay, the MBs (2.8 µm diameter)
functionalized with streptavidin were used to immobilize biotinylated AP through the
covalent streptavidin-biotin linkage. After the introduction of the AP-coated MBs into
the capillary, the buffer containing AP substrate was injected to fill the capillary and let
incubated for 30 min. Subsequently, the product was separated under low pressure
and detected by absorbance at 405 nm. Rashkovetsky et al. also developed another
MB-IMERs assay for HIV-protease [88]. In this assay, the substrate was immobilized
on the MBs through streptavidin-biotin binding while the enzyme HIV-protease was
later injected as a plug to the capillary. Following incubation, the product also migrated
toward the detector under low pressure and wasthen detected by LIF. The inhibition
of HIV-protease by acetyl-pepstatin resulted in the IC50 value that is consistent with
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the reported value in literature, indicating that CE-based assays coupled with MBIMERs are applicable to study not only enzyme activity but also enzyme inhibition.
Since its first application, CE assays coupled with MB-IMERs have been
developed by many groups for various enzymes, especially to adapt to the commercial
CE systems [18, 79, 82, 86]. Because the bead retention inside the capillary depends
on the external magnets, the placement of MBs is the key factor to the performance
of CE-integrated MB-IMERs. The magnet configurations of different shapes (square,
bar, cylindrical), orientations (repulsive and attractive), angles (0-90 degrees), and
different distances corresponding to different coolant systems were evaluated
theoretically and experimentally. Several groups attempted to simulate the magnetic
field and magnetic strength generated by single and double magnets using different
software such as FEMM, Flux Expert, and Quickfield [89-91]. The simulation studies
based on finite elements method by Bronzeau et al. and Gassner et al. both suggested
that attractive arrangement of two magnets at 90° result in strong magnetic field, thus
good MB plug formation [89, 90]. However, the microscopic images showed that the
MB plugs formed using this configuration are not consistent. The images reported by
Bronzeau et al. and Tarn et al., showed that the plug formed were not densely packed,
which is opposite to the observations of Gassner et al. [89, 90, 92, 93]. In another
simulation study using Quickfield software and Karlqvist method, Slovakova et al.
concluded that the most efficient arrangement involved the two rectangular magnets
in repulsive orientation, at angle of 30° to the separation channel. Imaging of the MBs
immobilized using this arrangement and similar design (20°) showed densely packed
MB plugs [91, 94, 95]. Interestingly, Henken et al. reported that the formation and
retention of MBs depends on the chemistry of the immobilized molecules on the beads
[95]. Typically the reproducibility of enzyme assays developed using the repulsive
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magnet configuration is at 20-25% [91, 96]. In most of the MB-based IMERs
constructed using the air-based cooling system, the magnets are placed directly onto
the capillary. Thus, the magnet-magnet and magnet-capillary distances are small,
resulting in high magnetic field inside the capillary. However, for the P/ACE MDQ
Beckman CE instrument that uses liquid-based cooling system, the capillary is inside
a coolant tubing, making it difficult to place the magnets in close proximity to the
capillary. As a result, it is more difficult to keep the MBs inside the capillary where the
magnetic field is reduced. Ramana et al. attempted to assemble the magnets to adapt
to this system in two ways [97, 98]. First, small cubic magnets were placed directly
onto the capillary and kept in place by tape. Since both the magnets and capillary fit
inside the tubing, this design enables the formation of MB plugs without having to
remove the tubing. Second, a magnet holder was created to hold the magnets in
attractive orientation, close to and at an angle of 30° to the coolant tubing. However,
both configurations exhibited poor reproducibility and significant loss of enzyme
activity.
1.4. Goals of this Dissertation
The goal of the research presented in this dissertation is to address limitations
of coupled enzyme assays using capillary electrophoresis (CE). The first approach is
to utilize CE to separate assay components (substrates, products, and inhibitors) for
direct UV absorption detection thereby avoiding the use of coupling enzymes. Enzyme
assays based on CE are less prone to spectral and inhibitor interferences relative to
coupled assays. The second approach involves developing a CE coupled enzyme
assay of ACC as a proof-of-concept, with fluorescence detection, using an LED to
replace lasers as an excitation source.
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Chapter 2. The goal of this project is to improve the CE enzyme assay and
apply the improved assay to study inhibition of bacterial ACC. Previously, a CE
enzyme assay was developed by Bryant et al. for bacterial holo-ACC [49], but it suffers
from limited peak shape and peak area reproducibility. The first objective in this project
is to improve the separation of ACC assay components including ADP, ATP, acetylCoA, and malony-CoA. The second objective is to apply the improved assay to
inhibition study of bacterial holo-ACC. The third objective is to determine IC50 values
of several inhibitors toward bacterial holo-ACC as well as the BC and CT subunits.
Chapter 3. The goal of this project is to develop a capillary electrophoretic
assay of human ACC2. A simple off-column capillary electrophoresis (CE) assay for
ACC2 was developed based on the separation of Mg-ADP, Mg-ATP, acetyl-CoA, and
malonyl-CoA with detection by UV absorption at 256 nm. The main difference between
human ACC2 and the bacterial holo-ACC is the requirement of citrate as an enzyme
activator for human ACC2. The buffer containing 30.0 mM HEPES, 3.0 mM KHCO3,
3.0 mM citrate, and 2.5 mM MgCl2 at pH 7.50 was used as both the separation and
sample buffers. When Mg2+ was absent from the separation buffer, the Mg-ADP and
Mg-ATP zones both split and migrated as two separate peaks. With Mg2+ added to the
separation buffer, Mg-ADP and Mg-ATP were detected as single peaks, and the
reproducibility of peak shape and peak area for human ACC2 assay components was
improved. To measure enzyme activity and screen for inhibitors of human ACC2, it is
desirable to utilize a separation method to avoid spectral interference. Inhibition of
human ACC2 by CP-640186, a known inhibitor, was studied using the CE assay.
Chapter 4. The goal of this project is to quantitatively compare a laser and LED
for capillary electrophoresis with fluorescence detection. Lasers have been used as a
common excitation source for fluorescence detection in CE owing to its powerful,
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coherent, monochromatic, and highly collimated output. Recently, light emitting diodes
have been used as an alternative to lasers due to their increasing commercial
availability, compact design, lower power consumption, lower cost, longer life time
(approximately 10,000 hours), and low maintenance. Signal-to-noise ratios (S/Ns) of
visible fluorophores were quantitatively compared as an LED with a nominal output
wavelength of 470 nm was used as an alternative to argon-ion laser lines at 488 nm,
472 nm, and 465 nm in laser-induced fluorescence detection with CE. Three
fluorophores were used for this study: fluorescein, rhodamine 123, and 5carboxyfluorescein. Optical fibers were used for excitation and collection of emission,
so the collimation of the laser relative to the LED is not an issue for the fluorescence
detector and comparison of sources. S/Ns were determined for all three fluorophores
at several excitation intensities for each source tested. Fluorophore excitation and
emission spectra, source spectra and the spectra of bandpass filters used for emission
were all considered in the analysis and comparison of S/N for different sources
Chapter 5. Conclusion and future directions
Appendix 1. The goal of this project is to develop an online assay that uses
coupling enzymes and CE separation. In the preliminary study, the CE online assay
of the second coupling enzyme, lactate dehydrogenase, was developed on a liquid
coolant-based CE system. The coolant tubing was modified with tubing of smaller size
to shorten the magnet-magnet and magnet-capillary distances while not obstructing
the coolant flow. The coupling enzymes lactate dehydrogenase was immobilized onto
magnetics beads, which were held inside the capillary under the magnetic field
generated by a pair of magnets. The NADH consumed in the assay was detected by
fluorescence, using a 365-nm LED as the excitation source. The dependence of NADH
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consumption on magnetic bead injection time, pyruvate concentration was
investigated.
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CHAPTER 2. INHIBITION STUDY OF BACTERIAL ACC
2.1. Introduction
Antibiotic resistance is a growing threat to the public’s health worldwide [99].
This is an inevitable side effect of antibiotic usage due to the bacteria developing
resistance to the drugs designed to kill them. Over years, the overuse and misuse of
antibiotics in medical treatment and agricultural settings have attributed to the
acceleration of antibiotic resistance. The bacteria can evolve and make the antibiotics
impotent in multiple ways. Some bacteria can change the outer structure to prevent
the antibiotic from permeating into the bacteria. Others modify or break down the
antibiotics before any harm is caused. Some bacteria can change the proteins that are
antibacterial targets in order to limit and block the effect of antibiotics [100, 101]. As a
consequence, a new antibiotic is only effective for a limited period of time after its first
introduction. After that, the bacteria still survive and multiply, causing untreatable fatal
infections. Despite the urgent need to develop new antibiotics, only 30 new antibiotics
and two new β-lactamase/β-lactam inhibitor combinations have been launched
between 2000 and 2015 [102]. The slow progress in antibiotic drug discovery is due
to the change in drug regulations, challenging commercialization, and the limited
number of drug targets [99, 103]. Recently, new targets for antibiotic drug development
have been identified, one of which is acetyl-coenzyme A carboxylase (ACC) [104].
ACC is an enzyme that catalyzes the first committed and rate-limiting step in
fatty acid biosynthesis [28]. This enzyme can be found in bacteria, plants, animals, in
which it catalyzes the biotin-dependent carboxylation of acetyl-CoA to form malonylCoA.

ACC

is

composed

of

three components:

biotin carboxylase (BC),

carboxyltransferase (CT), and biotin carboxyl carrier protein (BCCP). In vivo, the biotin
moiety is covalently bound to the BCCP subunit [7]. In bacteria, these three
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components can be isolated as separate proteins, with BC and BCCP expressed as
homodimers while CT is an α2β2 tetramer [50]. The ACC-catalyzed reaction proceeds
through two half-reactions. In the first half-reaction, BC catalyzes the ATP-dependent
carboxylation of the biotin moiety on BCCP. This reaction requires two metal ions,
typically Mg2+. The first Mg2+ is chelated to magnesium to form the Mg2+-ATP metalnucleotide complex which is the actual substrate. The second Mg2+ is bound to the
active site of the enzyme which interacts with the phosphate groups of ATP. As such,
the metal ions are thought to direct Mg2+-ATP to the active site cleft [7]. In the second
half-reaction, under the catalysis of CT, the carboxyl group is transferred from biotin
to acetyl-CoA to form malonyl-CoA. In bacteria, malonyl-CoA is the building block for
the synthesis of fatty acids, which are crucial for cell wall biosynthesis [105]. Therefore,
inhibiting ACC leads to limited bacterial cell wall synthesis and subsequently induces
cell death. Interestingly, either BC or CT can derive their own efficacy without the other
two ACC components, and the reactions catalyzed by these two subunits can utilize
free biotin as a substrate rather than the biotinylated BCCP [7]. As a consequence,
not only ACC but also BC and CT are attractive targets for antibacterial drug discovery.
Recently, antibacterial drug development has relied significantly on screening
botanical extracts. To date, 100,000 plant species have been tested for medicinal
purposes. Among 109 new antibiotics approved in 1981-2006, 69% were derived from
natural products [106]. Botanical extracts exhibit antibacterial properties owing to the
active compounds such as quinones, phenols, alkaloids, flavonoids [101]. Over 4000
flavonoids have been documented and classified into several sub-groups such as
flavonols, flavones, flavanones, and flavon 3-ol [107]. Flavonols, among the most
abundant flavonoids, are polyphenolic natural compounds frequently found in plants,
vegetables, and fruits, especially berries [108]. They are beneficial to human health
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owing to not only their antimicrobial activities but also antioxidant, anti-inflammatory,
anticarcinogenic, and antiviral properties. Flavonols consist of two aromatic rings (A
and B) linked by a 3-carbon chain that forms an oxygenated heterocyclic ring (C) and
hydroxyl groups substituted in C3 position (Figure 2.1). The hydroxyl group at C-3 and
hydroxyl groups on the aromatic rings attribute to the antimicrobial property of
flavonols [108]. Flavonols were reported to exhibit antibacterial activities in multiple
ways such as inhibition of nucleic acid synthesis, inhibition of cytoplasmic membrane
function or inhibition of energy metabolism [109]. For example, galangin, quercetin,
myricetin, and kaempferol demonstrated strong inhibition of DNA gyrase [109].
Quercetin was reported to disrupt membranes, decrease bilayer thickness, inhibit cell
envelope synthesis, and inhibit fatty acid synthesis (FAS-I) in mycobacteria among
others [106]. Similarly, myricetin inhibited FAS-I as well as DNA and RNA polymerases
[106]. Galangin showed strong inhibition against penicillinase (a type of β-lactamase)
from E.cloacae, and also altered the outer membrane permeability when combined
with amoxicillin [110]. Being pigments responsible for the color of leaves and fruits in
plants, flavonols strongly absorb in the UV range, which is a challenge for enzyme
inhibition studies due to spectral interference. Therefore, a method that enables
inhibitor screening with minimal spectral interference is needed.

Figure 2.1. The skeleton structure of flavonols
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Capillary electrophoresis (CE) has emerged as an analytical tool for
pharmaceutical research [79, 86, 111]. Enzyme assays based on CE have been
developed to study enzyme activity and applied to screen for enzyme inhibitors [76,
79, 111]. Compared to the conventional coupled enzyme assays, CE-based assays
offer several advantages. First, in a CE enzyme assay, the assay components
(substrates, products, inhibitors) are separated and quantified individually. This
enables the detection of enzyme activity without the spectral interference, which is a
drawback of coupled enzyme assays. Second, the CE assays allow for direct detection
of the assay components without the need of coupling enzymes, thus avoid the
complications from false positives in inhibitor screening. In addition, CE-based assays
require minute sample (nL) and can be implemented in online assays, making CE
more versatile a method to study enzymes.
Bryant et al. developed CE-based enzyme assays of not only the Escherichia
coli (E. coli) holo-ACC but also BC and CT [49]. Bryant and coworkers previously
studied the inhibition of botanical extracts and other flavonols towards holo-ACC, BC,
and CT [112]. It was observed that extracts from cranberry resulted in strong inhibition
of holo ACC, BC, and CT. Quercetin and myricetin, which are two abundant
compounds in cranberry extract [113-116], were found to inhibit not only holo-ACC but
also the BC and CT subunits [112]. These two compounds served as the structural
leads for the ligand homology analysis to identify other potential inhibitors of ACC.
Based on their commercially availability, three compounds: anrantine osage orange
(also known as natural yellow 8,11), galangin and 3,6-dihydroxyflavone (DHF) were
chosen for further study. Herein, the CE-based assays were used to study inhibition
of holo-ACC, BC, and CT by five flavonols (quercetin, myricetin, anrantine osage
orange, galangin and 3,6-dihydroxyflavone). The structures of these five compounds
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are shown in Figure 2.2. The IC50 values (the inhibitory concentration at half maximum
inhibition) for these five flavonols were measured to evaluate their potency towards E.
coli ACC, BC, and CT inhibition.

Quercetin

Anrantine osage orange

Myricetin

Galangin

3,6-dihydroxyflavone

Figure 2.2. Strutures of five flavonols in the inhibition study of holo-ACC, BC, and CT
2.2. Materials and Methods
2.2.1. Chemicals
ADP, ATP, acetyl-CoA, malonyl-CoA, biotin, biocytin, DMSO, sodium
hydroxide, potassium bicarbonate, magnesium chloride, sodium dedocyl sulfate,
quercetin, myricetin, and galangin were purchased from Sigma-Aldrich (St Louis, MO,
USA). Anrantine osage orange (natural yellow 8,11) was purchased from Aldrich
(Milwaukee, WI, USA), and 3,6-dihydroxyflavone was purchased from Alfa Aesar
(Heysham, Lancashire, UK). Potassium phosphate and sodium phosphate were
purchased from Fisher (Fairlawn, NJ, USA). The E. coli BC, CT, holo-ACC enzymes,
which were expressed following the procedures presented by Broussard et al. [47],
were obtained from the Waldrop Research Group. All solutions were prepared using
ultrapure water (>18 MΩ, Barnstead Nanopure, ThermoFisher, Marietta, Ohio, USA).
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All buffer solutions were filtered through 0.2 µm membranes (Whatman, Hilsboro, OR,
USA) before use.
2.2.2. Instrument
Capillary electrophoresis assays were performed using a P/ACE MDQ with a
PDA detector from Beckman Coulter (Brea, CA, USA). The data were collected and
analyzed using 32 Karat 5.0 software from Beckman Coulter. Fused-silica capillary
(50 µm i.d., 360 µm o.d.) was purchased from Polymicro Technologies (Phoenix,
Arizona, USA). A short segment of the polyimide coating on the capillary was removed
to create a detection window using a MicroSolv CE window maker (Eatontown, NJ,
USA). The IC50 values were calculated using Origin Pro 2016 software (OriginLab
Corporation, Northampton, MA, USA).
2.2.3. CE Assays
At the beginning of each day, the capillary was conditioned by rinsing with 1.0
M NaOH, ultrapure water, and separation buffer at 20.0 psi for 10.0 min each. Before
each run, the capillary was rinsed with the separation buffer at 20.0 psi for 1.0 min.
The samples were introduced to the capillary by hydrodynamic injection at 1.0 psi for
10 s.
The BC and CT assays were adapted from the assays developed by Bryant et
al. [49]. In the BC assay, the sample buffer contained 2.5 mM MgCl2, 5.0 mM KHCO3
and 5.0 mM potassium phosphate while the separation buffer contained 10.0 mM
sodium phosphate and 20.0 mM SDS, both at pH 7.50. The reaction mixtures contain
50.0 µM ATP, 2.5 mM MgCl2, 5.0 mM KHCO3, 50.0 mM biotin, 0.25% DMSO, and 0.5
µM BC. The separation was carried out in a 54.0 cm capillary with an effective length
of 44.0 cm, under the applied voltage of 30.0 kV (555 V/cm), with a current of 29.2 µA.
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For the CT assay, both the reaction buffer and separation buffer were 5.0 mM
potassium phosphate buffer at pH 7.50. The reaction mixture contained 100.0 µM
malonyl-CoA, 4.0 mM biocytin, 0.25% DMSO, and 0.05 µM CT. The capillary total
length was 38.6 cm, with an effective length of 28.6 cm (injection end to detection
window) A potential of 30.0 kV was applied to the separation (777 V/cm), with a current
of 16.6 µA.
The holo-ACC assay was based on the improved separation conditions
presented in Chapter 3. For this assay, the sample buffer contained 5.0 mM potassium
phosphate, 2.5 mM MgCl2, and 5.0 mM KHCO3 at pH 7.50 while the separation buffer
contained 5.0 mM sodium phosphate, 10.0 mM SDS, and 2.0 mM MgCl2 at pH 7.50.
The reaction mixtures contained 25.0 µM ATP, 50.0 µM acetyl-CoA, 5.0 mM KHCO3,
2.5 mM MgCl2, 5.0 mM potassium phosphate, 0.25% DMSO, and 31.8 µg/ml holoACC. The capillary total length was 38.6 cm, with an effective length of 28.6 cm. The
applied voltage was at 30.0 kV (777 V/cm), with a current of 30.6 µA.
2.2.4. Data Analysis
The inhibition of holo-ACC, BC, and CT by the flavonols was evaluated based
on v/v0 ratio in which v and v0 are the enzyme activity with and without an inhibitor,
respectively. The IC50 values were calculated by fitting the vi/vo ratios to the nonlinear
Logistic Model (OriginPro 2016):
y = A2 +

(A1 -A2 )
p

1+(x/x0 )

2.1

where y is the parameter corresponding to v/v0, A1 and A2 are the maximum
and minimum values of v/v0 , x is the concentration of the inhibitor, x0 is the
concentration of the inhibitor at the inflection point of the curve, and p is the Hill’s slope.
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The adjusted r-square is used to evaluate the goodness of fit. This parameter
is based on the coefficient of determination R2, and accounts for the degrees of
freedom.
2.3. Results and Discussion
2.3.1. BC Inhibition Study
For the BC assay, the reaction mixture contained 50.0 µM ATP, 2.5 mM MgCl2,
5.0 mM KHCO3, 50 mM biotin and 0.5 µM BC in a 5.0 mM sodium phosphate buffer
solution at pH 7.50. The BC-catalyzed reaction (Scheme 2.1) is the first half-reaction
in the ACC-catalyzed reaction. Herein, BC retains its catalytic activity using biotin as
a substrate:
- BC

ATP + biotin+ HCO3

-

ADP + biotin-COO + Pi

Scheme 2.1. Half-reaction catalyzed by BC
As the reaction proceeds, ATP depletes to produce ADP, both of which can be
detected by UV absorption at 256 nm. Figure 2.3 shows the separation of the reaction
mixture after 6.0 min incubation with and without the inhibitor (anrantine osage
orange). DMSO was added to all reaction mixtures to the final concentration of 0.25%
to help dissolve the flavonols. For the control sample to which 0.5 µM BC was added,
in addition to the ATP substrate peak at 8.8 min, an additional peak corresponding to
the ADP product was observed at 13.8 min. With 10-5 M anrantine osage orange added
to the reaction mixture, no ADP peak was observed, indicating that anrantine osage
orange inhibited the BC-catalyzed reaction.
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Figure 2.3. Electropherograms for the BC inhibition assay. The reaction mixtures
contain 50.0 µM ATP, 2.5 mM MgCl2, 5.0 mM KHCO3, 50.0 mM biotin, 0.25% DMSO,
and 0.5 µM BC without an inhibitor (control, solid red line) and with 10-5 M anrantine
osage orange (solid black line). The reaction time was 6.0 min. The assay condition
was described in Section 2.2.3.
The CE assay was applied to determine the IC50 values for the five flavonols.
The enzyme activity (v) is defined as the peak area ratio of ADP/(ADP+ATP). As such,
the precision of enzyme activity is improved by offsetting the fluctuation in sample
injection [77]. The dose dependence of BC inhibition by the flavonols was evaluated
based on the ratio vi/vo in which vi and vo are the enzyme activities in reactions with
and without the inhibitor, respectively. Figure 2.4 presents the dose-response curves
for the inhibition of BC by the 5 flavonols. Out of five compounds tested, only 3
compounds (myricetin, quercetin, and anratine osage orange) exhibited significant
inhibition towards BC as the flavonol concentration was increased up to 2.5 × 10-4 M.
The IC50 values calculated for myricetin, quercetin, and anrantine osage orange were
(5.3 ± 1.7) × 10-5 M, (6.6 ± 0.3) × 10-5 M, and (1.5 ± 0.2) × 10-5 M, respectively. It was
not practical to determine IC50 for galagin and DHF. Galagin (10-8 – 5.0 × 10-4 M) did
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not significantly inhibit BC whereas DHF slightly inhibited BC but its solubility (below
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Figure 2.4. Dose dependence of BC inhibition by flavonols. The error bars present the
standard deviations of vi/vo, each measured in triplicates.
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2.3.2. CT Inhibition Study
The CT assay is used to study the second half-reaction in the ACC assay and
proceeds in a non-physiological direction in which malonyl-CoA reacts to generate
acetyl-CoA. Previously, the CE-based assays were developed and applied to inhibition
study of CT [49, 52]. Biocytin, a more reactive analog of biotin (with maximal velocity
3 orders of magnitude higher than biotin), was used as a substrate for this assay [50].
The non-physiological reaction of malonyl-CoA and biocytin was catalyzed by CT as
follow:
malonyl-CoA + biocytin

CT

acetyl-CoA + carboxybiocytin

Scheme 2.2. Reverse half-reaction catalyzed by CT
For the CT assay, both the sample and the separation buffers contained 5.0
mM potassium phosphate at pH 7.50. The reaction mixtures contained 100.0 µM
malonyl-CoA, 4.0 mM biocytin, 0.25% DMSO, and 0.05 µM CT, which were allowed
to react for 4.0 min before being introduced to the capillary. The electropherograms
for the inhibition study of CT are shown in Figure 2.5. Compared to the control sample
(red solid line), the reaction mixture containing 10-5 M anrantine osage orange
generated a acetyl-CoA product peak of smaller area. This indicates that anrantine
osage orange inhibited the CT reaction. The CE-based assay was further applied to
study the inhibition of CT by 5 flavonols. Similar to the BC inhibition study, the IC50
value for each compound in the CT assay was determined by fitting the activity ratio
vi/vo to the Logistic model, the nonlinear regression model on the OriginLab software.
The activity in this assay is defined as the peak ratio acetyl-CoA/(acetyl-CoA +
malonyl-CoA). Plots showing the dependence of CT inhibition on the concentration of
the flavonols are shown in Figure 2.6.
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Figure 2.5. Electropherograms for the CT assay with anrantine osage orange. The
reaction mixtures contained 100.0 µM malonyl-CoA, 4.0 mM biocytin, 0.25% DMSO,
and 0.05 µM CT at reaction time of 4 min without an inhibitor (control, red solid line)
and with 10-5 M anrantine osage orange (black solid line). The assay condition was
described in Section 2.2.3.
Three compounds (myricetin, quercetin, and anrantine osage orange) inhibited
CT and yielded the IC50’s of (4.6 ± 1.4) × 10-7 M, (2.1 ± 0.5) × 10-6 M, and (6.5 ± 0.3)
× 10-7 M, respectively. These IC50’s are 23-115 fold lower than the corresponding
values for the BC assay, indicating that these inhibitors are more potent towards the
CT component of ACC. Meanwhile, galagin and DHF did not significantly inhibit CT
when tested up to 2.5 × 10-4 M and 1.0 × 10-4 M, respectively. Subsequently, only
myricetin, quercetin, and anrantine osage orange were chosen for further testing of
holo-ACC inhibition.
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Figure 2.6. Dose dependence of CT inhibition by flavonols. The error bars present the
standard deviations of vi/vo, each measured in triplicates.
2.3.3. Holo-ACC Inhibition Study
The separation conditions for the holo-ACC were modified from the assay
previously developed by Bryant et al [49]. In this assay, the reaction buffer contained
5.0 mM KHCO3, 2.5 mM MgCl2, and 5.0 mM potassium phosphate at pH 7.50. Initially,
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-3

the separation buffer containing 10.0 mM sodium phosphate with 20.0 mM SDS at pH
7.50 was used, resulting in splitting peaks of ADP and ATP. The work of Malina et al.
on the development of a PFK-1 assay, which also dealt with the separation of ADP
and ATP, suggested that this problem is associated with the exclusion of Mg2+ from the
separation buffer [77]. Upon the addition of Mg2+ to the separation buffer, ADP and
ATP were separated and detected as single peaks, presumably due to the complexes
Mg-ADP and Mg-ATP remaining at equilibrium when migrating in the separation buffer
containing Mg2+. The effect of Mg2+ on the separation of ACC assay components was
discussed in more details in Chapter 3. For the holo-ACC assay, a buffer containing
5.0 mM sodium phosphate, 10.0 mM SDS, and 2.0 mM MgCl2 was used as the
separation buffer.
Figure 2.7 shows the electropherograms for inhibition study of holo-ACC. The
reaction mixture contained 25.0 µM ATP, 50.0 µM acetyl-CoA, 5.0 mM KHCO3, 2.5
mM MgCl2, 5.0 mM potassium phosphate, 0.25% DMSO, and 31.8 µg/ml holo-ACC.
The reaction mixtures were let to react for 4.0 min before being injected to the capillary.
In the absence of an inhibitor, two peaks for the products, ADP and malonyl-CoA, were
observed in addition to the ATP and acetyl-CoA peaks. When 10-4 M anrantine osage
orange was added to the reaction mixture, holo-ACC was inhibited as evidenced by
the absence of the ADP and malonyl-CoA peaks. The IC50’s of the three flavonols
were calculated based on the nonlinear fitting of the enzyme activity ratio vi/vo to the
Logistic nonlinear regression model. The enzyme activity in this assay is defined as
the peak ratio of malonyl-CoA/(malonyl-CoA + acetyl-CoA).
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Figure 2.7. Electropherograms for holo-ACC inhibition study. Reaction mixtures
containing 25.0 µM ATP, 50.0 µM acetyl-CoA, 5.0 mM KHCO3, 2.5 mM MgCl2, 5.0 mM
potassium phosphate, 0.25% DMSO, and 31.8 µg/ml holo-ACC without an inhibitor
(control, red solid line) and with 10-4 M anrantine osage orange (black solid line) were
injected 4.0 min after incubation. The assay condition was described in Section 2.2.3.
Figure 2.8 shows the dependence of holo-ACC inhibition on the concentration
of the flavonols. The IC50’s calculated for myricetin, quercetin, and anrantine osage
orange were (6.7 ± 0.3) × 10-5 M, (5.2 ± 0.2) × 10-5 M, and (2.0 ± 0.2) × 10-5 M,
respectively. Table 2.1 summarizes the IC50 values for the five flavonols studied in this
project. Myricetin, quercetin, and anrantine osage orange inhibited not only holo-ACC
but also the BC and CT components. Interestingly, for all three compounds, the IC50’s
for holo-ACC and BC are comparable, and 25-146 times higher than the IC50’s for CT.
As such, the inhibitors are more potent towards the CT subunit than the BC subunit.
Hydroxyl substitution in flavonols is an important factor associated with bacterial
ACC inhibition. Tsuchiya et al. previously reported that the 5,7-dihydroxylation of the
A ring was critical for antibacterial activity [117]. Our results with the five flavonols are
in agreement with this hypothesis. Myricetin, quercetin, and anrantine osage orange
showed inhibition towards BC, CT, and holo-ACC owing to the hydroxyl groups at the
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C-4’, C-3, C-5, and C-7 positions. Due to limited solubility, DHF was only tested up to
1.0 ×10-4 M. Even at the highest concentration tested, DHF, which only has one
hydroxyl group at C-6 of the A ring did not significantly inhibit these enzymes.
Meanwhile, galangin, which also has the hydroxyl groups at C-3, C-5, and C-7
positions did not show significant inhibition of the tested enzymes. This suggests that
the 5,7-dihydroxylation of the A ring is not sufficient, and hydroxyl group substitution
at C-4’ is likely to enhance the inhibition of bacterial holo-ACC by flavonols. It was
previously reported that 4’-OH in flavonols did not only enhance the antibacterial
activity [109] but was also essential for the flavonols to inhibit influenza virus [118].
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Figure 2.8. Dose dependence of holo-ACC inhibition by myricetin, quercetin, and
anrantine osage orange. The error bars present the standard deviations of vi/vo, each
measured in triplicates.
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Myricetin, quercetin, and anrantine osage orange have the same hydroxyl
groups in the A- and C- rings but different hydroxyl substitutions in the B-ring.
Anrantine osage orange with two OH groups at C-2’ and C-4’ has the lowest IC50
values towards BC and holo-ACC relative to myricetin (with OH groups at C-3’, C-4’,
C-5’) and quercetin (with OH groups at C-4’ and C-5’). This finding suggests two
hypotheses. First, the hydroxyl substitutions at C-3’ and C-5’ are likely to decrease the
potency of the flavonols towards bacterial holo-ACC inhibition. A previous report by
Wu et al [109] also showed that the hydroxyl groups at these positions enhanced
antibacterial activity. Second, the hydroxyl group at C-2’ may enhance the inhibition of
bacterial holo-ACC by flavonols. Though there is no further evidence to support this
hypothesis on flavonols, the hydroxyl group at C-2’ of chalcones was assumed to be
essential for antibacterial activity [119]. Similarly, Tsuchiya et al. reported that the 2’,4’dihydroxylation in the B ring of the flavanones is important for anti-methicillin-resistant
S. aureus activity [117].
Relative to quercetin, myricetin, which has an additional OH group at C-3’,
exhibits lower IC50 values towards the BC and CT subunits but higher IC50 value
towards holo-ACC. This suggests that although the hydroxyl substitution at C-3’ is
associated with increased inhibitory efficiency of the BC and CT subunits, it still causes
the decrease in activity of the holo-ACC as a whole.
In addition to the position of the hydroxyl groups on the phenolic rings, the
degree of hydroxylation may also impact the inhibition of bacterial holo-ACC, BC, and
CT by phenolic compounds [107]. In this study, strong inhibition of holo-ACC, BC, and
CT was observed for myricetin, quercetin, and anrantine osage orange, which have 6,
5, and 5 hydroxyl groups, respectively whereas galangin and DHF with the
corresponding 3 and 2 hydroxyl groups did not significantly inhibit when tested up to
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2.5 ×10-4 M. This finding supports the hypothesis by Puupponen-Pimia et al. that the
higher degree of hydroxylations is associated with the higher antibacterial activity of
phenolic compounds [107]. However, myricetin has higher IC50 values for E. coli holoACC and BC, thus lower potency in inhibiting these enzymes compared to anrantine
osage orange although the former has one hydroxyl group more in the B ring.
Therefore, the structure-activity relationship associated with flavonols remains to be
clarified.
2.4. Conclusion
Capillary electrophoretic enzyme assays were applied to study inhibition of
holo-ACC, BC, and CT. Out of 5 flavonols tested, only myricetine, quercetin, and
anrantine osage orange inhibited the three enzymes. Galangin did not show significant
inhibition of holo-ACC, BC, and CT whereas DHF inhibited these three enzymes but
its solubility (< 1.0 × 10-4 M) is too poor to get IC50 quantitation. The IC50 values of the
flavonols depend on the position and number of hydroxyl groups. The 5,7dihydroxylation of the A ring is essential but not efficient for the flavonols to inhibit
bacterial holo-ACC. In addition, the hydroxyl groups C-4’ and C-2’ are likely to enhance
the inhibition of bacterial-ACC by flavonols whereas the hydroxyl groups at the C-3’
and C-5’ decrease the potency of the flavonols towards holo-ACC inhibition.
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Table 2.1. IC50 values of flavonols in BC, CT, and holo-ACC assays
Compounds

Structure

IC50 (M)
BC assay

IC50 (M)
CT assay

IC50 (M)
holo-ACC assay

Myricetin
(5.3 ± 1.7) × 10

-5

(4.6 ± 1.4) × 10

-7

(7.2 ± 1.3) × 10

-5

Quercetin
(6.6 ± 0.3) × 10

-5

(2.0 ± 0.3) × 10

-6

(5.3 ± 0.3) × 10

-5

Anrantine osage
orange
(1.5 ± 0.2) × 10

-5

(6.5 ± 0.3) × 10

-7

Galangin
N/A (negligible inhibition)

3,6dihydroxyflavone
N/A (poor solubility)
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(2.0 ± 0.2) × 10

-5

CHAPTER 3. CAPILLARY ELECTROPHORETIC ASSAY OF HUMAN
ACETYL-COENZYME A CARBOXYLASE 2*
3.1. Introduction
Acetyl-CoA carboxylase (ACC) catalyzes the carboxylation of acetyl coenzyme
A (CoA) to form malonyl-CoA in the committed step in fatty acid biosynthesis [45]. The
reaction proceeds via two half-reactions catalyzed by biotin carboxylase (BC) and
carboxyltransferase (CT), as shown in Scheme 3.1.

Mg-ADP + Pi

Mg-ATP + HC

Biotin Carboxylase

BCCP-Biotin

BCCP-Biotin-C

Carboxyltransferase

Malonyl-CoA

Acetyl-CoA

Scheme 3.1. ACC-catalyzed reaction
The first half-reaction, catalyzed by BC, uses magnesium-adenosine
-

triphosphate complex (Mg-ATP) to activate HCO3 by forming a carboxyphosphate
intermediate. The carboxyl group is transferred from carboxyphosphate to biotin,
which is covalently attached to the biotin carboxyl carrier protein (BCCP). The first
half-reaction requires two equivalents of Mg2+ for activity. One Mg2+ is bound to ATP

* Reprinted from Nguyen, T. H., Waldrop, G. L. and Gilman, S. D. (2019), Capillary
electrophoretic assay of human acetyl‐coenzyme A carboxylase 2. ELECTROPHORESIS. With
permission from John Wiley and Sons.
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so that the Mg-ATP metal-nucleotide complex is the substrate, while the other Mg2+ is
bound in the active site where it interacts with the phosphate groups of ATP [120, 121].
In the second half-reaction, CT catalyzes the transfer of the carboxyl group from biotinBCCP to acetyl-CoA to form malonyl-CoA. In most Gram-negative and Gram-positive
bacteria, BC, CT, BCCP are separate proteins [122]. The active form of the enzyme is
a complex of these three proteins (referred to hereafter as holo-ACC) [47]. In contrast,
in eukaryotes, these three proteins are domains on a single polypeptide chain [123].
In mammals, including humans, ACC exists in two isoforms [45, 124]. The
ACC1 isoform is a 265 kDa protein found in the cytosol of lipogenic tissues such as
liver, mammary gland, and adipose where the product, malonyl-CoA, is a substrate for
de novo fatty acid biosynthesis [45, 124, 125]. In contrast, the 280 kDa ACC2, is highly
expressed only in the mitochondria of oxidative tissues such as skeletal muscle,
cardiac muscle, and occasionally in liver [59, 60]. In these tissues, malonyl-CoA
regulates fatty acid oxidation by inhibiting carnitine palmitoyltransferase I, and
ultimately blocking the entry of fatty acids into the mitochondria for β-oxidation [27].
Both isoforms of human ACC are targets for the treatment of disease states.
Knockout mice missing the gene for ACC2 do not gain weight even on a high-fat diet,
suggesting that ACC2 is a target for anti-obesity agents [32]. Inhibition of ACC1 and
ACC2 can be used to reduce hepatic de novo lipogenesis and treat metabolic
disorders such as nonalcoholic steatohepatitis [37, 126]. Also, the expression of the
gene coding for ACC1 is upregulated in several cancer types, indicating an increased
need for fatty acids and thereby making ACC1 a target for anti-cancer drugs [43].
Despite both isoforms of ACC being targets for pharmaceutical intervention, there is a
dearth of inhibitors of the enzymes for clinical testing. A robust and effective assay for
screening inhibitors of ACC would be timely and useful.
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Several different methodologies have been used to assay the activity of
eukaryotic ACC. Early assays utilized radiochemicals such as H14CO3 [11, 30, 34, 60,
65] and [γ-32P] ATP [29]; however, radiolabeled based assays have significant
disadvantages, including safety and radioactive waste disposal regulation. In contrast,
coupled enzyme assays are relatively benign. Coupled enzyme assays of ACC have
been developed to measure the production of adenosine diphosphate (ADP) [11, 29,
30], inorganic phosphate (Pi) [61, 62], or malonyl-CoA [63]. While coupled enzyme
assays are facile for many kinetic measurements, they can be problematic for inhibitor
screening. The cost of the coupling enzymes can be prohibitive. More importantly,
coupled enzyme assays, especially those utilizing NADH/NADPH, can be problematic
for detecting enzyme inhibition due to spectral overlap with the inhibitors. Additionally,
inhibition of the coupling enzymes is likely to cause false positive in inhibitor screening.
Recently, LC-MS/MS has been used to detect the formation of malonyl-CoA [66].
While the LC-MS/MS assay is a direct, selective and sensitive measure of malonylCoA, it requires an expensive instrument run by highly-skilled personnel.
Capillary electrophoresis has emerged as a versatile separation-based platform
for development of enzyme assays [18, 127, 128]. Using CE to measure enzyme
activity and inhibition has several advantages, starting with the small amounts of
enzyme, substrate, and inhibitors utilized for a typical CE-based enzyme assay. When
the assay components can be separated and detected directly, coupled enzymes are
not required, reducing complexity and the likelihood of false positives for enzyme
inhibition studies. Electrophoretic separation of substrates, products, and inhibitors in
CE-based assays minimizes the potential for spectral interference from inhibitors.
Recently, a CE enzyme assay for ACC from E. coli was developed [49]. This assay
can be used for holo-ACC-catalyzed reactions as well as the half-reactions catalyzed
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by the isolated BC and CT components. The CE assay proved to be particularly useful
for assessing inhibition of ACC by compounds that exhibited spectral interference with
the coupled enzyme assay that utilizes NADH/NADPH [52]. Given the medical
relevance of human ACC, a similar CE assay for the human enzyme would be useful;
however, human ACC behaves differently than the bacterial form, in that, activity
requires citrate to activate the enzyme via polymerization of the protomeric subunits
into a filamentous form [129]. This aspect of human ACC2 makes the development of
a CE assay for human ACC more challenging than for bacterial ACC. In this report, a
CE assay for human ACC2 is described along with demonstration that the assay can
detect ACC2 inhibition.
3.2. Materials and Methods
3.2.1. Chemicals
Human acetyl-CoA carboxylase 2, ADP, ATP, acetyl-CoA, malonyl-CoA,
DMSO, sodium hydroxide, potassium bicarbonate, potassium citrate, magnesium
chloride, and HEPES were purchased from Sigma-Aldrich (St Louis, MO, USA). TrisHCl was purchased from Promega (Madison, MI, USA). Potassium phosphate and
sodium phosphate were purchased from Fisher (Fairlawn, NJ, USA). The inhibitor
[(3R)-1-[1-(anthracene-9-carbonyl)piperidin-4-yl]piperidin-3-yl]-morpholin-4ylmethanone (CP-640186) was obtained from AdooQ Bioscience (Irvine, CA, USA).
Solutions were prepared using ultrapure water (>18 MΩ, Barnstead Nanopure,
ThermoFisher, Marietta, Ohio, USA). Buffer solutions were filtered through 0.2 µm
membranes (Whatman, Hilsboro, OR, USA) before use.
3.2.2. Instrumentation
A P/ACE MDQ with a PDA detector from Beckman Coulter (Brea, CA, USA)
was used for CE assays. Data were collected and analyzed using 32 Karat 5.0
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software from Beckman Coulter. Fused-silica capillary (50 µm id, 360 µm od) was
purchased from Polymicro Technologies (Phoenix, Arizona, USA). A short segment of
the polyimide coating on the capillary was removed to create a detection window using
a MicroSolv CE window maker (Eatontown, NJ, USA). The capillary total length was
38.6 cm, with an effective length of 28.6 cm (from the injection end to the detection
window).
3.2.3. CE Conditions
At the beginning of each day, the capillary was rinsed with 1.0 M NaOH,
ultrapure water, and separation buffer at 20.0 psi for 10.0 min each. Before each run,
the capillary was rinsed with the separation buffer at 20.0 psi for 1.0 min. A buffer
solution containing 30.0 mM HEPES, 3.0 mM MgCl2, 2.5 mM KHCO3, and 2.5 mM
potassium citrate at pH 7.50 was used as both the sample and separation buffers
unless noted. All enzyme-catalyzed reactions proceeded at room temperature, and
the capillary temperature was kept constant at 25 °C. Human ACC2-catalyzed reaction
mixtures were prepared in a total volume of 100 µL. All samples were
hydrodynamically injected at 0.5 psi for 5.0 s, followed by separation at 19.5 kV (505
V/cm) with ultraviolet (UV) absorption detection at 256 nm.
3.3. Results and Discussion
3.3.1. Separation of Nucleotides using Capillary Electrophoresis
The ACC2 assay based on CE depends on the separation and quantification of
the nucleotide substrates and products – ATP, ADP, acetyl-CoA, and malonyl-CoA.
Previous CE assays for bacterial ACC [49] and phosphofructokinase-1 [77] included
methods for the separation of nucleotides based on earlier published separations [130,
131]; however, the development of the ACC2 assay inspired a reexamination of those
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previous nucleotide separations. This reexamination of the separation is relevant to
the development of other CE-based assays for enzymes with nucleotide substrates.

ATP

ADP

Acetyl-CoA

Malonyl-CoA

O

N

O
N

N

Carboxylated biotin
CP-640186
Figure 3.1. Structures of ADP, ATP, acetyl-CoA, malonyl-CoA, CP-640186 and
carboxylated biotin. The added carboxyl group on carboxylated biotin is shown in red
and boldface.
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The separation approach presented here is still based on CE with UV
absorption detection as ADP, ATP, acetyl-CoA, and malonyl-CoA all absorb strongly
at 256 nm (Figure 3.1 and Figure 3.2).
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Figure 3.2. UV absorption spectra of 250 µM ADP, ATP, acetyl-CoA, malonyl-CoA,
and CP-640186. The spectra were collected using CE with a PDA detector.
The separation method for an enzyme assay must strike a balance between
optimal solution conditions for the enzyme-catalyzed reaction and conditions suitable
for the reproducible separation of the substrates and products. The injected sample
will contain the solution used for the enzyme-catalyzed reaction, and its injection must
not degrade the CE separation. Separation of these four molecules has been
demonstrated previously for an assay of a bacterial form of ACC [49], but the optimum
solution conditions for bacterial ACC and human ACC2 are significantly different [30,
47, 49, 66, 129]. Therefore, the separation was revisited, taking into consideration the
reaction requirements of human ACC2 and our experience working with bacterial ACC
and phosphofructokinase-1 (PFK-1), another Mg2+-dependent enzyme [77]. Figure 3.3
shows an electropherogram obtained using conditions developed for the bacterial
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holo-ACC enzyme assay where the sample buffer was 5.0 mM potassium phosphate,
2.5 mM MgCl2, and 5.0 mM KHCO3 at pH 7.50, and the separation buffer was 10.0
mM sodium phosphate and 20.0 mM SDS at pH 7.50 [49].
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Figure 3.3. Electropherogram for the separation of holo-ACC assay components using
the conditions from Bryant et al. [49]. The sample solution contained 50.0 µM ADP,
50.0 µM ATP, 100.0 µM acetyl-CoA, 100.0 µM malonyl-CoA in a buffer containing 5.0
mM potassium phosphate, 2.5 mM MgCl2, and 5.0 mM KHCO3 at pH 7.50. The
separation buffer was 10.0 mM sodium phosphate and 20.0 mM SDS at pH 7.50. The
sample was injected hydrodynamically at 0.5 psi for 5.0 s and then separated at 19.5
kV (505 V/cm) with a current of 26.7 µA.
Although this separation has been used successfully for quantitative assays of
bacterial holo-ACC and its inhibition, this method occasionally suffered from
reproducibility problems and peak splitting for ADP and ATP (Figure 3.3). Separation
of ADP and ATP alone resulted in the formation of double peaks for each compound,
similar to split peaks reported for naphthol separations in borate and attributed to
multiple complexes formed by naphthols and borate [132]. Later work by Malina and
coworkers on the development of a CE assay for PFK-1 shed light on the issue [77].
This assay also required separation of ATP and ADP, and similar problems were
encountered. The substrate for both ACC and PFK-1 is ATP complexed to Mg2+, so
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Mg2+ must be included in the reaction solution, which is injected into the CE capillary
for the enzyme assays. Separation reproducibility for PFK-1 was improved markedly
by adding 1.0 mM Mg2+ to the separation buffer. The peaks in the CE separations were
Mg-ATP and Mg-ADP complexes, and the additional peaks in the electropherograms
with poor reproducibility were attributed to dissociation of Mg-ATP and Mg-ADP during
the CE separations without Mg2+ in the separation buffer [77].
Based on this result for PFK-1, the conditions for the bacterial holo-ACC
enzyme assay were modified to include 2.0 mM Mg2+ in the separation buffer, and
Figure 3.4 shows a resulting electropherogram. The separation buffer contained 5.0
mM sodium phosphate, 10.0 mM SDS, and 2.0 mM MgCl2 at pH 7.50, while the sample
buffer still contained 5.0 mM potassium phosphate, 5.0 mM KHCO3 and 2.5 mM MgCl2
at pH 7.50. The separation buffer and sample buffer differ because of the conflicting
requirements for the separation and enzyme assay (sample buffer). Potassium in the
sample buffer increases the enzyme activity but causes SDS to precipitate, so
potassium phosphate was used only in the sample buffer. The KHCO3 in the sample
buffer provides bicarbonate and potassium for the reaction but would precipitate SDS
in the separation buffer. The concentrations of individual solution components were
also adjusted to try to keep the ionic strengths of the two solutions similar in order to
reduce deleterious effects (focusing, defocusing, system peaks, etc.) [133, 134].
The addition of Mg2+ to the separation buffer improved the separation of ACC
assay components compared to previous results (Figure 3.4 vs. Figure 3.3). Peak
splitting of ADP and ATP was eliminated, similar to the findings of Malina et al. [77].
The later migrating ATP and ADP peaks disappear, including the peak overlapping
with malonyl-CoA (Figure 3.3). The remaining Mg-ATP and Mg-ADP peaks migrating
before acetyl-CoA are better resolved with Mg2+ in the separation buffer (Figure 3.4).
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Based on dissociation constants for Mg2+ complexes with ADP and ATP of 0.30 mM
and 0.019 mM [135], about 91% of ADP and 99% of ATP will exist as Mg-ADP− and
Mg-ATP2- in the sample solution containing 3.0 mM MgCl2, 50.0 µM ADP and 50.0 µM
ATP. The migration of acetyl-CoA and malonyl-CoA are largely unaffected by the
addition of Mg2+ to the separation buffer, indicating they are not complexed to Mg2+.
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Figure 3.4. Electropherogram for the improved separation of holo-ACC assay
components. The sample solution contained 50.0 µM ADP, 50.0 µM ATP, 100.0 µM
acetyl-CoA, and 100.0 µM malonyl-CoA in a buffer containing 5.0 mM potassium
phosphate, 2.5 mM MgCl2, and 5.0 mM KHCO3 at pH 7.50. The separation buffer was
5.0 mM sodium phosphate, 10.0 mM SDS, and 2.0 mM MgCl2 at pH 7.50. The sample
was injected hydrodynamically at 0.5 psi for 5.0 s and separated at 19.5 kV (505 V/cm)
with a current of 19.5 µA.
The surfactant, SDS, frequently has been used in CE methods for separating
ADP and ATP [49, 77, 130, 131], but removal of SDS from the separation buffer for
ACC assays would reduce the mismatch of sample and separation buffers and avoid
problems with SDS precipitation due to potassium in the reaction buffer. In an effort to
eliminate SDS, a buffer containing 5.0 mM potassium phosphate, 5.0 mM KHCO3, and
2.5 mM MgCl2 at pH 7.50 was used as both separation and sample buffer for the

77

separation of Mg-ADP, Mg-ATP, acetyl-CoA, and malonyl-CoA as shown in Figure
3.5.
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Figure 3.5. Electropherogram for the separation of ACC assay components without
SDS. The sample solution contained 50.0 µM ADP, 50.0 µM ATP, 100.0 µM acetylCoA, 100.0 µM malonyl-CoA. The separation buffer and sample buffer both contained
5.0 mM potassium phosphate, 5.0 mM KHCO3, and 2.5 mM MgCl2 at pH 7.50. The
sample was injected hydrodynamically at 0.5 psi for 5.0 s and then separated at 19.5
kV (505 V/cm) with a current of 19.8 µA.
The four compounds were baseline resolved, and the migration order of the
four components did not change after eliminating SDS (Figure 3.5 vs Figure 3.4). SDS
was not used in subsequent experiments.
3.3.2. Adaptation of the Separation for the Human ACC2 Assay
Bacterial holo-ACC and human ACC2 both catalyze the conversion of acetylCoA to malonyl-CoA as shown in Scheme 3.1. A CE-based assay for both enzymes
requires the separation of Mg-ATP, Mg-ADP, acetyl-CoA, and malonyl-CoA; however,
there are significant differences in the optimal reaction conditions for these two
enzymes. Human ACC2 requires citrate as an enzyme activator with reported Ka
values of 0.3-10.0 mM [30, 66, 136]. Therefore, the human ACC2 reaction solution
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must contain ATP, acetyl-CoA, KHCO3, MgCl2, and citrate. Based on reported Km
values and concentrations of the substrates and cofactors used in previously reported
human ACC assays, the concentrations used for the enzyme assay solution were
100.0 µM ATP, 50.0 µM acetyl-CoA, 3.0 mM MgCl2, 2.5 mM KHCO3, and 2.5 mM
potassium citrate [30, 62, 65, 66, 136].
Solutions buffered with HEPES and Tris-HCl were evaluated for the separation
of Mg-ADP, Mg-ATP, acetyl-CoA, and malonyl-CoA. Although phosphate buffer
worked for the bacterial holo-ACC assay [49], the interaction of phosphate and Mg2+
has the potential to negatively impact assay reproducibility due to the low solubility
products of Mg2+ with phosphate in aqueous solution [Ksp = 1.5×10-6 for
MgHPO4·3H2O, 2.0×10-24 for Mg3(PO4)2 ·22H2O, and 5.2×10-24 for Mg3(PO4)2] [137].
HEPES (pKa 7.55) and Tris-HCl (pKa 8.3) were tested as alternatives to phosphate for
the ACC enzyme assay based on previous use [11, 30, 34, 62, 65, 66, 124, 136]. The
buffering ranges of HEPES and Tris-HCl cover the pH values at which human ACC
assays were performed (pH 7.5-8.0) [11, 30, 34, 62, 65, 66, 124]. Unlike phosphate,
these two buffers do not bind to Mg2+ [138], which makes them ideal for the ACC
assay.
The HEPES and Tris-HCl buffers contained 2.5 mM KHCO3, 2.5 mM potassium
citrate and 3.0 mM MgCl2 at pH 7.50 with either 30.0 mM HEPES or 30.0 mM TrisHCl. At a field strength of 505 V/cm, the electrophoretic currents in HEPES and TrisHCl buffers were 27.4 µA and 49.6 µA, respectively, which makes HEPES-containing
buffer less prone to deleterious Joule heating during electrophoresis.
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Figure 3.6. Electropherogram for the separation of human ACC2 assay components
using a Tris buffer. The sample solution contained 50.0 µM ADP, 50.0 µM Mg-ATP,
100.0 µM acetyl-CoA, 100.0 µM malonyl-CoA. The separation buffer and sample
buffer both contained 30.0 mM Tris-HCl, 3.0 mM MgCl2, 2.5 mM KHCO3, and 2.5 mM
potassium citrate at pH 7.50. The sample was injected hydrodynamically at 0.5 psi for
5.0 s, then separated at 19.5 kV (505 V/cm) with a current of 49.6 µA.
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Figure 3.7. Electropherogram for the separation of human ACC2 assay components
using a HEPES buffer. The sample solution contained 50.0 µM ADP, 50.0 µM MgATP, 100.0 µM acetyl-CoA, 100.0 µM malonyl-CoA. The separation buffer and sample
buffer both contained 30.0 mM HEPES, 3.0 mM MgCl2, 2.5 mM KHCO3, and 2.5 mM
potassium citrate at pH 7.50. The sample was injected hydrodynamically at 0.5 psi for
5.0 s, then separated at 19.5 kV (505 V/cm) with a current of 27.4 µA.
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Separation of assay components in both HEPES buffer and the Tris-HCl buffer
resulted in well-separated peaks (Figure 3.7 and Figure 3.6), but the migration time of
the last peak, malonyl-CoA, was more than twice as long for the Tris-HCl separation
compared to the HEPES separation (15.2 min vs 7.0 min). The reproducibility of peak
areas obtained using HEPES buffer is comparable to those obtained using phosphate
buffers (Table 3.1). A buffer containing 30.0 mM HEPES, 2.5 mM KHCO3, 2.5 mM
potassium citrate, and 3.0 mM MgCl2 at pH 7.50 was chosen as both the sample and
separation buffer for further development and characterization of the human ACC2
assay.
Table 3.1. Relative standard deviation of Mg-ADP, Mg-ATP, acetyl-CoA, and malonylCoA peak areas with different separation buffers (N=3).
Separation Buffer
RSD (peak area), %
(pH 7.50)
Mg-ADP
Mg-ATP
Acetyl-CoA Malonyl-CoA
10.0 mM sodium
4.0
4.0
2.5
5.7
*
phosphate, 20.0 mM SDS
5.0 mM sodium
2.2
1.4
2.2
3.0
phosphate, 10.0 mM SDS,
2.0 mM MgCl2*
5.0 mM potassium
2.4
1.8
1.8
1.6
phosphate, 5.0 mM
KHCO3, 2.5 mM MgCl2
30.0 mM HEPES, 2.5 mM
1.3
1.8
1.3
2.2
KHCO3, 2.5 mM
potassium citrate, 3.0 mM
MgCl2
*The sample buffers contained 5.0 mM potassium phosphate, 5.0 mM KHCO3,
and 2.5 mM MgCl2 at pH 7.50. Otherwise, the separation and sample buffers were the
same.
In addition to acetyl-CoA, ATP, Mg2+, KHCO3, citrate and HEPES, the reaction
solution for the ACC2 assay will contain components from the enzyme storage
solution. Testing the effect of these on the separation is essential. According to the
product information provided by the manufacturer, human ACC2 is in a buffered
aqueous solution containing Tris-HCl (pH 8.0), NaCl, 10-20% glycerol, and DTT, with
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the possible presence of EDTA, KCl, imidazole, and TWEEN-20. The human ACC2
enzyme solution was added up to 10% v/v to the assay mixture.
A buffer solution consisting of 50 mM Tris-HCl, 275 mM NaCl, 10% glycerol,
and 1.0 mM EDTA at pH 8.0 was prepared to mimic the ACC2 storage buffer and was
used to test the effect of the enzyme storage buffer on the separation of human ACC2
assay components. The additional salts and glycerol in the enzyme storage buffer will
result in a mismatch between the EOF of the separation buffer and the sample zone,
which should reduce separation efficiency (broader peaks) [139]; however, with the
simulated enzyme storage buffer added at 10% v/v to the assay solution to mimic
assay conditions, the anionic assay components were still well resolved, and the
separation efficiency was actually enhanced 1.2-3.2 fold (Table 3.2).
Table 3.2. Number of theoretical plates calculated for the separation of 50.0 µM ADP,
50.0 µM ATP, 40.0 µM acetyl-CoA, and 40.0 µM malonyl-CoA with and without
simulated enzyme storage buffer added to the sample solution.
Analyte
ADP
ATP
Acetyl-CoA
Malonyl-CoA

Theoretical plates (x104 plates), N=3
0% simulated storage buffer
10% simulated storage buffer
2.20 ± 0.04
2.70 ± 0.15
1.80 ± 0.11
4.18 ± 0.05
1.96 ± 0.07
5.45 ± 0.03
1.76 ± 0.10
5.59 ± 0.50

Sample self-stacking or isotachophoresis could lead to the observed efficiency
increases, but most examples of these in the literature include suppression of EOF or
reversed polarity for CE [133, 140, 141]. Wei et al. reported increased separation
efficiency for nucleic acids and FITC in presence of glycerol and high salt
concentration without polarity reversal or EOF suppression, similar to our conditions
with the enzyme storage buffer [142]. The authors did not provide a convincing
explanation for their observations, but they are consistent with our results.
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Quantification of the assay substrates and products was not significantly
impacted by the enzyme storage buffer. Table 3.3 summarizes the calibration curves
obtained for Mg-ADP, Mg-ATP, acetyl-CoA, and malonyl-CoA with and without 7%
simulated enzyme storage buffer. In all cases, the R2 values for a linear fit of the data
were greater than 0.99. Analysis of the slopes confirmed (95% confidence) that the
slopes were the same with and without the simulated enzyme storage buffer [143].
Table 3.3. Calibration curves of ADP, ATP, acetyl-CoA, and malonyl-CoA without and
with 7% simulated enzyme storage buffer. The concentration range for the calibration
curves is from 2.5 to 150.0 µM.
Compound
ADP
ATP
Acetyl-CoA
Malonyl-CoA

Without simulated storage
buffer
y = 69.6x - 148.4
R² = 0.9986
y = 156.5x - 153.4
R² = 0.9992
y = 132.1x - 191.5
R² = 0.9993
y = 19.1x - 60.1
R² = 0.9986

With simulated 7% storage
buffer
y = 71.2x - 165.9
R² = 0.9944
y = 153.5x - 176.8
R² = 0.9946
y = 128.7x - 340.4
R² = 0.9955
y = 20.0x - 175.5
R² = 0.9944

3.3.3. CE Assay for Human ACC2
Electropherograms for an assay of human ACC2 using the HEPES separation
buffer are presented in Figure 3.8. Figure 3.8A is an electropherogram before the
addition of enzyme, and peaks are observed for 100.0 µM of Mg-ATP and 50.0 µM
acetyl-CoA. Figure 3.8B shows the separation of reaction components 18 min after
adding 7.0 µL human ACC2 to the total volume of 100.0 µL (final human ACC2
concentration of 25 nM). As expected, two product peaks (Mg-ADP and malonyl-CoA)
were observed while the peak areas of Mg-ATP and acetyl-CoA decreased.
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Figure 3.8. Electropherogram for human ACC2 assay.(A) The reaction mixture
contained 100.0 µM ATP, 50.0 µM acetyl-CoA, and 1.0% DMSO prior to the addition
of enzyme. (B) The reaction mixture at 18 min after the addition of 25 nM human
ACC2. Other conditions are the same as in Figure 3.7.
It is interesting to note that the separation efficiency of Mg-ATP and acetyl-CoA
in Figure 3.8B increased by 1.8 and 2.3 fold, respectively, relative to the separation in
Figure 3.8A. This is consistent with our results with the simulated enzyme buffer (Table
3.2). The peak labeled with an asterisk at 6.9 min is an unidentified compound likely
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associated with the decomposition of acetyl-CoA. A control experiment showed that
this peak is not CoA, and more detail about our efforts to understand this peak are
included in Figure 3.9. The unidentified peak could be minimized by freshly preparing
acetyl-CoA solutions, and it did not interfere with the assay.
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Figure 3.9. Electropherograms for separation of acetyl-CoA solutions prepared and
stored in water for 5 months (blue line), in a buffer containing 30.0 mM HEPES, 3.0
mM MgCl2, 2.5 mM KHCO3, and 2.5 mM potassium citrate for 1 week (black line), and
in HEPES-containing buffer for 1 week, spiked with 100.0 µM CoA (red line). The peak
denoted with an asterisk (*) indicates the unidentified impurity or degradation product
of acetyl-CoA.
DMSO is commonly used to solubilize enzyme inhibitors before dilution in
aqueous solution, and it was important to understand the impact of DMSO on human
ACC2 activity. Like other organic solvents, DMSO can alter enzymatic reactions by
changing enzyme conformations or interacting with substrates, products, and coenzymes [144]. The effect of DMSO on ACC2 activity was examined by adding DMSO
to the reaction solution at final concentrations of 0.0-3.0%. Reaction progress curves
for the human ACC2-catalyzed reaction at different DMSO concentrations are
presented in Figure 3.10.
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Figure 3.10. Progression curve showing the dependence of malonyl-CoA production
on the concentration of DMSO at reaction time up to 79 min (0% DMSO, 3.0% DMSO),
60 min (1.0% DMSO, 1.5% DMSO), and 46 min (0.5% DMSO). The reaction mixtures
contained 100 µM ATP, 50 µM acetyl-CoA, 25 nM human ACC2, and DMSO at
concentrations from 0.0 - 3.0% v/v. The separation buffer and sample buffer both
contained 30.0 mM HEPES, 3.0 mM MgCl2, 2.5 mM KHCO3, and 2.5 mM potassium
citrate at pH 7.50. The samples were injected hydrodynamically at 0.5 psi for 5.0 s,
then separated at 19.5 kV (505 V.cm-1) with a current of 27.4 µA.
Enzyme activity was calculated as the ratio of malonyl-CoA concentration to the
total concentration of malonyl-CoA and acetyl-CoA. This normalization enhances the
precision of CE-based enzyme assay, reducing the effects of inconsistencies in
sample injection and separation [77]. Human ACC2 exhibited the highest activity in
the absence of DMSO. The enzyme activity dropped 3 fold at 0.5% DMSO but only
1.5 fold at 1.0-3.0% DMSO. A DMSO concentration of 1.0% was chosen for inhibition
experiments to keep the organic solvent content as low as possible while obtaining
adequate enzyme activity.
3.3.4. Inhibition of Human ACC2
A known inhibitor of human ACC2, CP-640186 (Figure 3.1), was used to
evaluate the applicability of our CE assay to detect ACC2 inhibition. CP-640186 was
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tested at 250 µM, well above its reported IC50 value of 61 nM [34]. Figure 3.11 shows
an electropherogram for an injection 18 min after the addition of 25 nM human ACC2
to a reaction mixture containing 250 µM CP-640186, 100.0 µM Mg-ATP, and 50.0 µM
acetyl-CoA.
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Figure 3.11. Electropherogram for inhibition of human ACC2. The sample solution
contained 100.0 µM ATP, 50.0 µM acetyl-CoA, 1.0% DMSO, 250 µM CP-640186, and
25.2 nM human ACC2. Other conditions are the same as in Figure 3.7.
In the presence of the inhibitor, peaks for Mg-ADP and malonyl-CoA were not
detected, indicating that CP-640186 fully inhibited human ACC2 at this concentration.
It is important to note that CP-640186 strongly absorbs at 256 nm (Figure 3.2). As
shown in Figure 3.11, an extra peak for CP-640186 was detected at 2.0 min in addition
to peaks of DMSO (negative), Mg-ATP, and acetyl-CoA. In our CE assay, all the assay
components were separated prior to UV detection at 256 nm, which eliminated
spectral

interference

caused

by

the

inhibitor,

spectrophotometric assays.
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3.4. Conclusion
This paper demonstrated a simple, direct, off-column CE-based enzyme assay
developed to study activity and inhibition of human ACC2. This CE-based assay
enables the measurement of enzyme activity and screening of inhibitors by
simultaneously monitoring the depletion of Mg-ATP and acetyl-CoA accompanying
with the formation of Mg-ADP and malonyl-CoA. All the assay components and CP640186 were separated in well-resolved peaks, making spectral interference, a
common issue with spectrophotometric assays, unlikely when screening for inhibitors.
A previous assay for bacterial ACC served as the foundation for this work, and
significant improvements were made for the ACC2 assay. Reproducibility problems
associated with dissociation of Mg-ADP and Mg-ATP when migrating in separation
buffer not containing Mg2+ were also addressed by adding Mg2+ to the separation
buffer. SDS was eliminated from the separation buffer and the potential for problematic
interactions of phosphate with the Mg2+ in the separation buffer was eliminated by
switching to a HEPES buffer. These improvements to the separation are also
applicable to the bacterial ACC assay and other CE enzyme assays based on the
separation of nucleotides.
This optimized ACC2 assay will be useful for screening of potential inhibitors of
human ACC2, which is a starting point to develop new anti-cancer or anti-obesity
drugs. Because the two isoforms of human ACC catalyze the same reaction, we
expect the CE assay for human ACC2 to be applicable for human ACC1 although
further experiments will be required to confirm this.
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CHAPTER 4. QUANTITATIVE COMPARISON OF A LIGHT-EMITTING
DIODE AND LASER FOR FLUORESCENCE DETECTION WITH
CAPILLARY ELECTROPHORESIS
4.1. Introduction
Capillary electrophoresis (CE) has developed into a powerful and versatile tool
for bioanalytical separations. While the small scale of CE is critical to some of its main
advantages relative to other analytical separation techniques (small sample volumes,
high efficiency and speed), sensitive detection for CE has been a related challenge
since the technique’s emergence in the 1980’s. Capillary electrophoretic separation
performed in microchips, also known as microchip electrophoresis (ME), offers
additional advantages compared to CE (smaller scale, speed, sample handling), but
detection for ME is even more challenging than for CE due to small channel
dimensions. Fluorescence detection is, to date, the second most common detection
method for CE and the dominant detection method for ME [71, 145-147]. Although UVVis absorption detection is a more universal a detection method compared to
fluorescence, for CE and ME, fluorescence detection is better able to overcome the
associated short optical path lengths for detection at low concentrations, providing the
LOD up to 1000 fold lower than absorbance [145-147]. Laser-induced fluorescence
(LIF) detection was introduced early in the development of CE [148, 149] and was the
first detection method used for ME [150]. Detection of just a few molecules and even
single molecules was later demonstrated using CE-LIF and ME-LIF [72, 73, 151, 152].
Lasers have been used extensively as excitation sources for fluorescence
detection with CE and ME because they are monochromatic, highly collimated, and
powerful. However, drawbacks of lasers can include high cost, high power
consumption, bulky cooling systems, and short lifetimes (depending on the type of
laser and wavelength). Recently, the drive towards light sources of lower cost, lower
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power consumption, longer lifetime, higher stability and easier operation has led
scientists to light-emitting diodes (LEDs). Relative to lasers, commercially available
LEDs are cheaper, easier to use, and consume less power while functioning without
the need of bulky cooling systems. In addition, the LEDs generate continuous
emission, commonly of 30 nm full width at half maximum (FWHM), which are
advantageous for excitation at a wide range of wavelengths.
Since the 1990’s, LEDs have been explored as alternative excitation sources
to lasers for fluorescence detection in CE and ME with applications in pharmaceutical
studies, including detection of amino acids or DNA analysis [74] [153-156]. The LODs
for the fluorescence detection in CE have been enhanced by modification of the
detectors or by using spectral filtering [153, 154, 157]. Bruno et al. [153] designed a
pigtail detector coupled to a green LED (λmax = 560 nm) for capillary electrophoretic
separation with LED-induced fluorescence (LEDIF) detection of rhodamine B,
resulting in an LOD of 10-7 M. In another study by Dasgupta et al. [154], a capillary
was used as the liquid core waveguide detection cell, which was coupled with two blue
LEDs (λmax = 470 nm and λmax = 495 nm) for the LEDIF detection of fluorescein with
an estimated LOD of 8.0 ×10-9 M. In a study by Uchiyama et al., a blue LED (λmax =
476 nm) was used as the excitation source for the LEDIF detection of FITC-labeled
amino acids in microfluidic electrophoresis, resulting in LODs of 160 µM for valine and
90 µM for phenylalanine [156]. Alternatively, a miniaturized version of liquid core
waveguide-capillary electrophoresis system was developed, using blue LEDs (λmax =
478 nm) as the excitation source for fluorescence detection of FITC-labeled amino
acids [155]. This set up allowed for the detection of FITC-labeled phenylalanine at the
LOD of 1.9 µM, which was 47 fold lower compared to the study by Uchiyama et al.
[155, 156]. In addition to the modified detector, the optimization of spectral filtering
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also enhanced fluorescence detection in CE-LEDIF. According to de Jong et al., when
using the 467 nm LED with a 470 nm band pass filter, the S/N for riboflavin was
improved by a factor of 70. Although there has been success with LEDs for
fluorescence detection, the low LODs obtained with CE and ME-LIF have not been
matched.
LEDs have been referred to as the sources of high stability and low noise [158160]. However, the data on stability and noise of LEDs is very limited. Previously,
LEDs were compared to lasers as excitation sources for fluorescence detection of
labeled amino acids and antibodies in CE [159, 160]. Rodat-Boutonnet et al. reported
the separation of IgG labelled with three fluorophores (naphthalene-2,3-dialdehyde, 3(2-furoyl)-quinoline-2-carboxaldehyde,

and

5-carboxytetramethylrhodamine

succinimidyl ester) using SDS capillary gel electrophoresis with fluorescence detection
[159]. Different LEDs (450-nm, 480-nm, and 530-nm LEDs) and lasers (410-nm, 488nm, and 532-nm laser diodes) served as excitation sources and were compared
quantitatively based on the S/Ns. It was demonstrated that the LEDs resulted in the
same or higher S/Ns than the lasers. However, the LEDs and lasers were not
employed at the same output power, with the LED intensities at 2-6 times higher than
that of the lasers. Also, because the output powers were not optimized, it was not clear
how the S/Ns were affected by LED and laser output powers as photobleaching and
ground-state depletion occur at high excitation intensity [161]. The baselines of SDS
capillary gel electrophoresis with the 480-nm LED and 488-nm laser were also
compared, and the LEDIF technique was indicated to provide slightly higher lowfrequency noise and lower high-frequency noise than the LIF. However, while noise
depends on the source power, it was not clear if the LED and laser were compared at
the same output power. In another work by Enzonga and coworkers [160], the amino
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acids labeled with FITC were separated by CE and detected by LIF and LEDIF, using
a 488-nm diode laser and a 470-nm LED as excitation sources. The LEDIF detection
resulted in higher S/Ns (1.7-2.5-fold) and lower LODs (1.9-2.5-fold) than the LIF.
However, the LED output power was reported to be 150 mW while information on the
diode laser output power was missing. Therefore, a quantitative study that clearly
establishes the relative performance of LEDs and lasers as excitation sources is still
lacking.
In this work, a 470-nm LED and a tunable argon ion laser were quantitatively
compared as excitation sources for fluorescence detection of three common, visible
fluorophores with a commercial CE instrument. The S/Ns and LODs were compared
in order to evaluate the relative performance of the two sources. For the comparison
of the LED and laser, all experimental conditions such as separation conditions,
fluorophore concentrations, output power (measured at the output end of the optical
fiber), and optical filters were identical. The LED and laser were coupled to a 400 µm
optical fiber for excitation, so the lack of collimation of the LED source was not an issue
for the comparison. The overall impact of source emission spectra, fluorophore
excitation and emission spectra, and optical filters on fluorescence detection were all
considered.
4.2. Materials and Methods
4.2.1. Chemicals
Boric acid and sodium hydroxide were purchased from Fisher (Fair Lawn, NJ,
USA). 5-carboxyfluorescein (5-FAM) were obtained from Fluka (Steinheim, Slovakia).
Fluorescein, rhodamine 123, and ethanol were purchased from Sigma (St. Louis, MO,
USA). Borate buffer (50.0 mM, pH 9.00) was prepared from boric acid and sodium
hydroxide in 18 MΩ deionized water (Barnstead Nanopure, ThermoFisher, Marietta,
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Ohio, USA). Fluorescein and 5-FAM solutions were prepared in borate buffer. A stock
solution of rhodamine 123 was prepared in ethanol and diluted in borate buffer. All
solutions were filtered through 0.2-µm membranes (Whatman, Hilsboro, OR, USA)
before use.
4.2.2. Instrumentation
All

separations

were

performed

using

a

P/ACE

MDQ

Molecular

Characterization System (Beckman Coulter, Fullerton, CA, USA) equipped with a LIF
detector module utilizing a 520/20 nm emission filter and a 488-nm notch filter. Data
were acquired with 32 Karat software version 7.0 (Beckman Coulter, Brea, CA, USA)
and analyzed using Microsoft Excel (Microsoft Corporation, Redmond, WA, USA).
Capillary electrophoretic separations were performed in fused-silica capillaries
(Polymicro Technologies, Phoenix, Arizona, USA) of 49 µm ID and 362 µm OD with a
total length of 38.5 cm and an effective length of 28.5 cm. A blue fiber-coupled highpower LED (M470F1, Thorlabs, Newton, NJ, USA) with nominal wavelength of 470
nm and adjustable power output controlled by a T-cube LED driver (Thorlabs, Newton,
NJ, USA) was used as an excitation source for CE-LEDIF. An air-cooled argon ion
laser (43 series ion laser, Melles Griot, Carlsbad, CA, USA) with tunable wavelengths
was used for CE-LIF detection. An optical fiber with a core diameter of 400 µm and a
numerical aperture of 0.29 (Ocean Optics, Dunedin, FL, USA) was coupled to the 470nm LED by an SMA-905 connector and to the laser by focusing laser beam directly to
one end of the optical fiber. The output power of the LED and laser lines were
measured at the other end of the optical fiber, which is coupled to the LIF detector
module, using a broadband power/energy meter (13PEM001, Melles Griot, Carlsbad,
CA, USA). LED emission spectral characterization at different output powers was
performed using an Avantes-2408 spectrometer (Broomfield, CO, USA). A UV-Vis-
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NIR scanning spectrophotometer (UV-3101PC, Shimadzu, Kyoto, Japan) was used to
characterize the emission and notch filters. The excitation and emission spectra of the
fluorophores

were

collected

using

a

Varian

Cary

Eclipse

fluorescence

spectrophotometer (Victoria, Australia).
4.2.3. CE conditions
The capillary was conditioned daily by rinsing at 20.0 psi with 1.0 M NaOH for
10 min, deionized water for 10 min, and borate buffer for 10 min. Borate buffer (50.0
mM, pH 9.00) was used as both the sample buffer and separation buffer in this
experiment. Between runs, the capillary was rinsed with borate buffer for 0.5 min at
20.0 psi. The samples were introduced into the capillary by hydrodynamic injection at
1.0 psi for 10.0 s and separated at 30.0 kV (779 V/cm).
4.3. Results and Discussion
4.3.1. Separation of Fluorophores
Three fluorophores were chosen for this study: rhodamine 123, fluorescein, and
5-FAM. The structures of three fluorophores are shown in Figure 4.1.

Rhodamine 123

Fluorescein

5-FAM

Figure 4.1. Structures of rhodamine 123, fluorescein, and 5-FAM
Normalized excitation and emission spectra collected for 1.0 µM rhodamine
123, fluorescein, and 5-FAM in 50.0 mM borate buffer (pH 9.00) are presented in
Figure 4.2.
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Figure 4.2. Excitation and emission spectra of rhodamine 123, fluorescein, and 5-FAM
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The LED emission spectra and the laser lines at 457 nm, 465 nm, 472 nm, 476
nm, and 488 nm all overlap with the excitation spectra of the fluorophores, which
enables the comparison of the LED and laser as the excitation sources for
fluorescence detection of the rhodamine 123, fluorescein, and 5-FAM.
Rhodamine 123, a fluorescent cationic dye, has been used for biomedical
applications including in vitro drug transport assays, and is a product of the reaction
between dihydrorhodamine-123 and reactive oxygen species [162, 163]. Fluorescein,
an anionic fluorophore, and its derivatives have been widely used to label amino acids,
proteins and peptides [72, 146, 164-166]. A derivative of fluorescein, 5-FAM, which
has one carboxyl group attached to fluorescein, can be used to label proteins,
peptides, and nucleotides through the reaction of the carboxyl group with the primary
amines [164]. In aqueous solution pH 9.00, the phenol and carboxylic acid functional
groups in fluorescein and 5-FAM are ionized, and these compounds exist as anions.
Electropherograms showing the separation of the three fluorophores are
presented in Figure 4.3. In this study, a buffer solution of 50.0 mM borate at pH 9.00
was used as both the sample and separation buffer. When the sample was introduced
to the capillary in a longer hydrodynamic injection (1.0 psi for 10.0 s), wide, flat-topped
peaks were obtained (Figure 4.3 A). The precision of the S/N ratio measured for these
peaks is therefore improved without significantly compromising the separation. A short
injection of the sample (0.5 psi for 5.0 s) resulted in sharp peaks of the fluorophores,
as shown in Figure 4.3 B. Hydrodynamic injections at 1.0 psi for 10.0 s were used for
all subsequent experiments.

96

0.35

A
5-FAM

0.30
Fluorescein

0.25

RFU

0.20
Rhodamine 123
0.15
0.10
0.05
0.00
-0.05
0.5

1.0

1.5

2.0

2.5

3.0

Time (min)

0.35

B
5-FAM

0.30
Fluorescein

0.25

RFU

0.20
Rhodamine 123

0.15
0.10
0.05
0.00

-0.05
0.5

1.0

1.5

2.0

2.5

3.0

Time (min)

Figure 4.3. Electropherograms of 50 nM rhodamine 123, 50 nM fluorescein, and 50
nM 5-FAM with excitation by the LED at 5.5 mW. Injection conditions: A) 1.0 psi, 10.0
s, and B) 0.5 psi, 5.0 s.
4.3.2. Comparison of S/N for Different Light Sources
The S/N values for detection of the three fluorophores were compared using
the LED and laser excitation at the same output power with identical separation
conditions, the same commercial CE instrument, and the same fluorescence detection
module. Figure 4.4 shows the S/N calculated for the three fluorophores using the 470nm LED as well as the 465-nm, 472-nm and 488-nm lines from a tunable air-cooled
argon ion laser as the excitation sources.
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Figure 4.4. S/N for detection of 50.0 nM rhodamine 123, 50.0 nM fluorescein, and 50.0 nM 5-FAM using the 470-nm LED, 465-nm,
472-nm and 488-nm laser lines as excitation sources. The error bars present the standard deviations of the S/Ns, each measured in
triplicates.
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The excitation output power was increased from 1.0 mW in 1-mW increments
up to the maximum output available for each source, except for the 488-nm laser line,
which was increased up to 14.0 mW. Generally, the S/N increased as the output power
of each source increased. The plots for rhodamine 123 and fluorescein 123 show
evidence of reaching plateaus starting at 5-6 mW, which is likely due to a combination
of singlet saturation and photobleaching [161].
For all three compounds excited by the LED and laser lines with the same
output power at the fluorescence detector, the raw S/N values were the highest for the
488-nm laser line, followed by the 472-nm and 465-nm laser lines, and the lowest S/N
values were obtained with the 470-nm LED. Although this simple comparison was
performed with the same fluorophores, instrument and source intensities, it does not
account for differences in the emission spectra of the 470-nm LED and laser lines
relative to the excitation spectra of the three fluorophores and the optical filters used
in the fluorescence detector. Consideration of these issues will provide a more
complete view of the relative performance of these sources [71, 149, 157, 161].
4.3.3. Characterization of the LED
Unlike lasers, commercial LED sources of the same type do not have identical
emission wavelengths, and their emission spectra will shift as the output power is
changed by adjusting the forward current [167]. Typically LEDs are sold with only a
nominal peak emission wavelength listed as was the case with the LED used in this
work. In order to investigate the potential impact of the LED output power on CE
detection, emission spectra of the LED (nominally 470 nm) were collected at different
LED output intensities. The output power of the 470-nm LED was measured at the
outlet of the optical fiber as in the CE experiments. Figure 4.5 presents the output
spectra for the LED as the power was increased. In Figure 4.5A, the spectra were
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normalized by total output power from 300 to 600 nm (areas under each spectrum are
identical). Alternatively, the spectra can be normalized by peak output power (Figure
4.5B). As the current was increased from 150 mA up to 1000 mA, the corresponding
LED output power increased from 1.0 mW up to 6.6 mW and the peak wavelength
shifted from 468 nm to 465 nm, with the full width at half maximum (FWHM) increasing
from 19 to 25 nm. The blue shift and spectral broadening of the LED emission due to
increasing forward current was previously reported and attributed to the band-filling
effect of the localized energy states and the screening of the piezoelectric field in the
strained multiple quantum well region [167].
Although broad-band emissions of LEDs are advantageous for excitation of
fluorophores at a wide range of wavelengths, polychromaticity is a pernicious factor in
fluorescence detection. The commercial LED used in this study has 19-25 nm FWHM
while the Stokes’ shifts for rhodamine 123, fluorescein, and 5-FAM are 21 nm, 21 nm,
and 25 nm, respectively. Since the LED bandwidth is comparable to the Stokes’ shift
for the fluorophores, it is feasible for the LED emission to overlap with the emission
filter [157], which scarcely occurs when a laser is used as an excitation source.
The long wavelength component of the LED, that may coincide with the
fluorescence emission contributes to the background signal, and consequently
degrades the signal-to-noise ratio (S/N) or limit of detection (LOD) measurements
[157]. Emission and notch filters have been used simultaneously to address this issue
by removing unwanted scattered light at the detection wavelength from the LEDs and
allowing the emitted signal to go through. According to de Jong et al., when using
proper spectral filters, the S/N for riboflavin was improved by 70 times [157].
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Figure 4.5. Normalized emission spectra of the 470-nm LED at output power from 1.0
mW to 6.6 mW. The spectra were normalized by peak output power (A) and total
output power (B).
Figure 4.6 presents the transmission spectra of the 488 nm notch filter and the
520/20 nm notch filter in this study. In this study, as the power of the LED was
increased from 1.0 mW to 6.6 mW, the tail of the LED (from 500 nm to 596 nm)
increased from 2.5% to 2.9% of the total LED power. Even with the use of the filters,
8.8%-9.4% of the tail (0.22%-0.26% of the total LED power) that coincides with the
fluorescence detection wavelength still passed through these filters, giving rise to
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significant background signal. Such an issue does not apply for the laser lines which
are effectively blocked by the filters. As a consequence, the S/N values for the
fluorescence detection of the fluorophores was lower when using the LED as the
excitation source. Figure 4.7 shows the emission spectra of the LED and laser lines
along with transmission profiles of the 488-nm notch filter and 520/20 nm emission
filter.
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Figure 4.6. Spectra of a 488-nm notch filter and a 520/20 emission filter
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Figure 4.7. Emission spectra of the LED and laser lines, and transmittance profiles of
a 488-nm notch filter and a 520/20 nm emission filter.
4.3.4. Comparison of S/N Adjusted for Light Source-Fluorophore Spectral
Overlap
The aim of the experiments presented in Figure 4.4 was to directly compare the
S/N values that could be obtained with LEDIF and LIF under separation and detection
conditions that were as experimentally similar as possible. Differences in spectral
overlap between the emission spectra of the sources and the excitation spectra of the
fluorophores can have a significant impact on the S/N. This is particularly true for the
LED which has a very broad spectral output (Figure 4.5) compared to the laser lines.
To quantitatively evaluate this effect, an adjusted excitation intensity, Іadj ,ex , was
calculated for each source-fluorophore combination. Herein, Іadj ,ex , represents the
total light intensity that a fluorophore absorbed from an excitation source whose
spectra were normalized by the total output power. The adjusted excitation intensity
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of the fluorophores using the LED as an excitation source was calculated using the
following equation:

600

І adj ,ex =


i 300

m( , 1)  x )
i i
i

4.1

where m( , 1) is the emission intensity of the LED over a 1 nm increment
i i
from i to

i  1 as presented in Figure 4.5 B, and xi is the normalized excitation

intensity of the fluorophore at wavelength i as presented in Figure 4.2.
The output power of the LED was spread over a broad range of wavelengths
relative to the laser lines. The range from 300 nm to 600 nm was selected for these
calculations because outside this range, the light intensity is negligibly low (10-4-10-3%
the total output power). Table 4.1 presents the adjusted excitation intensities of the
fluorophores at different LED output powers. The adjusted excitation intensities of the
fluorophores decreased by 5.1%-5.4% when the LED output power increased from 1.0
mW to 6.6 mW due to the blue shift in LED peak emission and broadening of the LED
output spectrum (Figure 4.5).
Since laser lines are effectively monochromatic with typical 0.0004 nm FWHM
[168], their adjusted excitation intensities for each fluorophore were calculated using
the following equation:

І adj ,ex = m  x
i

i

4.2

where Іadj ,ex is the adjusted excitation intensity of the fluorophore, m is
i
the emission intensity of the laser line at wavelength

i , and xi is the normalized

excitation intensity of the fluorophore at wavelength i as presented in Figure 4.2.
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The adjusted excitation intensities of rhodamine 123, fluorescein, and 5-FAM
at the five laser lines are presented in Table 4.2. Because the output wavelength and
FWHM for the output spectrum will not vary significantly with output power, a single
value is presented for each source. A 1-nm width for the laser centered at the emission
line was used so that the adjusted excitation intensities calculated by Equation 4.2 can
be compared to the value calculated in Equation 4.1. The differences observed
between sources are due to the difference in the line wavelength and fluorophore
excitation spectra.
Table 4.1. Adjusted excitation intensity of rhodamine 123, fluorescein, and 5-FAM at
different LED output powers

LED power (mW)
1.0
2.1
3.2
4.4
5.5
6.6

Adjusted excitation intensity
Rhodamine 123
Fluorescein
5-FAM
(λex=498 nm)
(λex=491 nm)
(λex=493 nm)
0.466
0.495
0.477
0.455
0.484
0.466
0.451
0.480
0.462
0.446
0.474
0.456
0.441
0.470
0.452
0.445
0.474
0.456

Table 4.2. Adjusted excitation intensity of rhodamine 123, fluorescein, and 5-FAM at
different laser lines

laser line (mW)
457
465
472
476
488

Adjusted excitation intensity
Rhodamine 123
Fluorescein
5-FAM
(λex=498 nm)
(λex=491 nm)
(λex=493 nm)
0.302
0.331
0.318
0.397
0.410
0.398
0.473
0.496
0.471
0.528
0.588
0.550
0.832
0.962
0.921

Comparison of Table 4.1 and Table 4.2 shows that the 488-nm laser line
exhibits the best overlap with all three fluorophores. The 465-nm laser line was closest
to the LED emission peak wavelength (465-468 nm) while the 472-nm laser line
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exhibited the adjusted excitation intensities closest to those of the LED for all three
fluorophores. Therefore, the 472 nm, and 465 nm were chosen for further comparison
with the LED. The 488-nm line was also considered because it is the most commonly
used laser line for CE-LIF and ME-LIF.
Figure 4.8 presents the S/Ncorrected for the three fluorophores using the LED
and 488-nm, 472-nm, and 465-nm laser lines for excitation. The corrected signal-tonoise ratios were calculated using Equation 4.3:

S / Ncorrected 

SN
Іadj ,ex

4.3

where S/Ncorrected is the corrected signal-to-noise ratio, S/N is the raw
signal-to-noise ratio (Figure 4.4), and Іadj ,ex is the adjusted excitation intensity
calculated using either Equation 4.1 or Equation 4.2. Correcting these plots to account
for source-fluorophore spectral overlap results in the S/N ratios for the three laser lines
being almost identical, but the S/N obtained with the LED is significantly lower in all
cases (2-4 times lower). The difference in S/Ncorrected is likely due to the tail of the
LED that was ineffectively blocked by the optical filters, as discussed in Section 0. The

S/Ncorrected in CE-LEDIF can be improved by optimizing the spectral filter to reduce
the optical noise associated with the LED [157, 169].

106

400

Rhodamine 123

600

A

B

Fluorescein

500

300
Corrected S/N

Corrected S/N

400

200
488 nm laser
472 nm laser
100

300
488 nm laser

200

472 nm laser

465 nm laser
100

470-nm LED

465 nm laser
470-nm LED

0
0.00

2.00

4.00

6.00

8.00

0
0.00

10.00 12.00 14.00 16.00

2.00

4.00

6.00

8.00

10.00 12.00 14.00 16.00

Output power (mW)

Output power (mW)
2000

5-FAM

C

Corrected S/N

1500

1000
488 nm laser
472 nm laser
465 nm laser

500

470-nm LED
0
0.00

2.00

4.00

6.00

8.00

10.00 12.00 14.00 16.00

Output power (mW)
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each measured in triplicates.
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4.3.5. Limits of detection
The LODs of rhodamine 123, fluorescein, and 5-FAM obtained using the LED
and laser lines as excitation sources are summarized in Table 4.3. The power of 5.5
mW was selected for the comparison because it was the highest power output that
could be generated by all sources used in the study (Figure 4.4). These LOD values
were not adjusted for source-fluorophore spectral overlap (Section 4.3.4). For all three
fluorophores, the lowest LODs were obtained with the 488-nm laser line, followed by
the 465-nm and 472-nm laser lines. The LODs obtained with the 470-nm LED were 420 times higher than those obtained with the 488-nm laser line. The spectral overlap
data (Table 4.1 and Table 4.2) would only account for 2-fold difference. Taking this
into account, the LOD’s obtained with the 488-nm laser line would still be 2-10 times
lower and the ineffective blocking of unwanted scattered emission from the LED by
the spectral filters.
Table 4.3. LODs obtained for the fluorophores with the 470-nm LED and laser lines
(output power = 5.5 mW) as excitation sources
Excitation source
470-nm LED
465-nm laser line
472-nm laser line
488-nm laser line

Rhodamine 123
4
1
2
1

Limit of detection (nM)
Fluorescein
5-FAM
3
2
0.6
0.2
0.7
0.7
0.3
0.6

4.4. Conclusion
The LEDs are promising alternatives to the lasers for fluorescence detection
due to their small size, low cost, and simple operation. However, spectral overlap of
the LED emission spectrum with the fluorophore excitation spectrum as well as the
optical filter transmittance spectrum should be taken into account. We have
demonstrated that the 470-nm LED used for the detection of three fluorophores
including rhodamine 123, fluorescence, and 5-FAM yielded the S/N values 2-4 times
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lower than the 465-nm, 472-nm, and 488-nm laser lines, even when the overlap of
fluorophore-source was taken into account. In addition, the limits of detection for the
fluorophores were 3-20 times lower with the laser lines compared to the 470-nm LED.
The underperformance of the LED compared to the laser lines is due to the ineffective
filtering of the LED emission at long wavelengths. With the use of the 488 nm notch
filter and 520/20 nm emission filter, a portion of the LED tail at long wavelengths (500
nm - 596 nm), which accounted for 0.22%-0.26% the total output of the LED, still
reached the detector due to the overlap of LED emission with the fluorophore emission
spectra. This attributed to the higher noise and lower S/N values obtained with the
LED compared to the laser lines. Therefore, optimizing the spectral filter is important
in order to improve the S/N and LOD in CE-LEDIF.
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CHAPTER 5. CONCLUSION AND FUTURE DIRECTIONS
5.1. Conclusion
In this dissertation, capillary electrophoresis-based assays were developed to
address limitations of coupled enzyme assays. The first approach was to develop and
apply direct off-line enzyme assays to separate assay components (substrates,
products and inhibitors). The second approach was to use coupling enzymes in
combination with CE to reduce spectral and inhibition interferences associated with
the coupling reactions.
Chapter 2 presents first the application of CE assays to determine the IC50
values for inhibitors of bacterial holo-ACC, BC, and CT. The inhibition study of
bacterial holo-ACC, BC, and CT by five flavonols (myricetin, quercetin, anrantine
osage orange, galangin and 3,6-dihydroxyflavone) was performed using the CE offline assays. These compounds were selected previously based on CE screening and
computational studies. Out of the five flavonols, myricetin, quercetin, and anrantine
osage orange all strongly inhibited the three enzymes. DHF inhibited BC and CT but
its solubility (<1.0 × 10-4 M) was too low for IC50 quantification whereas galagin
exhibited insignificant inhibition towards the three enzymes. The IC50 values for
myricetin, quercetin, and anrantine osage orange were determined and compared to
explore the structure-activity relation of the flavonols towards inhibition of bacterial
holo-ACC, BC, and CT. The IC50 values of the flavonols depend on the position of
hydroxyl groups. The 5,7-dihydroxylation of the A ring is insufficient for inhibition of
holo-ACC, BC, and CT. In addition, the hydroxyl groups C-4’ and C-2’ are likely to
enhance the inhibition of bacterial ACC by flavonols whereas the hydroxyl groups at
the C-3’ and C-5’ decrease the potency of flavonols. The IC50 values determined in
the holo-ACC and BC assays are comparable, but are 2 order of magnitude higher
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than the IC50 values in the CT assay. Chapter 2 shows that simple CE-based assays
can be applied to study bacterial holo-ACC, BC, and CT inhibition without the need of
coupling enzymes.
Chapter 3 presents the first CE assay developed for human ACC2. The
separation conditions were based on a previously developed CE offline assay for
bacterial ACC, which was successfully applied for inhibition study but occasionally
suffered from reproducibility issues and peak splitting of ADP and ATP. First, Mg2+
was added to both the sample and separation buffers to improve the separation
reproducibility. Second, citrate was added to the buffer to activate the enzyme. Third,
SDS was removed from the separation buffer to avoid the mismatch of sample and
separation buffers while avoiding problems with SDS precipitation due to potassium in
the reaction buffer. Finally, phosphate was replaced by HEPES to eliminate the
potential problematic interaction of Mg2+ with phosphate. The assay was then
demonstrated to detect the inhibition of human ACC2 by CP-640186, a known
inhibitor. The CE assay of human ACC2, which was developed without coupling
enzymes, is applicable to inhibition study with minimal spectral interference.
For the second approach to address limitations of coupled enzyme assays, a
CE online coupled assay will be monitored by measuring the fluorescence of NADH
using a LED as the excitation source. Chapter 4 presents the quantitative comparison
of a 470-nm LED to argon laser lines at 457, 465, 472 and 488 nm as the excitation
sources for fluorescence detection of rhodamine 123, fluorescein, and 5carboxyfluorescein with CE separation. The S/Ns obtained using the LED were 2-7
times lower compared to the laser lines at the same output power. When corrected for
the difference in fluorophore excitation, which is presented as the spectral overlap of
the fluorophore excitation and light source emission spectra, the corrected S/Ns
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obtained for the fluorophores using the LED were still 2-4 times lower than using the
laser lines. The underperformance of the LED compared to the laser lines might be
due to a portion of the LED emission at long wavelength (or the LED “tail”) that was
not effectively blocked by the optical filters used for isolating fluorescence emission.
Even with the use of a 488-nm notch filter (57 nm FWHM) and the 520/20 nm emission
filter, 0.22%-0.26% the total output of the LED, which corresponds to the unfiltered
portion of the LED tail, still reached the detector and contributed to the higher noise
and lower S/N values obtained with the LED compared to the laser lines.
Appendix 1 presents preliminary results in the development of a CE online
coupled assay on a liquid coolant-based CE system. A portion of the coolant tubing
was modified with smaller tubing dimension to decrease the magnet-magnet and
magnet-capillary distances while not obstructing the coolant flow. The coupling
enzyme lactate dehydrogenase was immobilized onto magnetic beads, which were
held inside the capillary by the magnetic field generated by a pair of rare earth
magnets. In the CE online assay of the second coupling enzyme (lactate
dehydrogenase), the negative peak corresponding to the consumed NADH was
detected by fluorescence, using a 365-nm LED as the excitation source. The magnetic
bead injection time and pyruvate concentration were demonstrated to impact the
NADH consumption in the online assay.
5.2. Future Directions
In this dissertation, only five flavonols (myricetin, quercetin, anrantine osage
orange, galangin, and DHF) were tested. Other flavonoids including flavanols,
flavones, flavanones can also be tested using the developed assays to identify
potential inhibitors of bacterial holo-ACC, BC, and CT. Similar to flavonols, these are
the phenolic compounds that can be found in botanical extracts. The potency of the
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inhibitors can also be evaluated based on the calculated IC50 values. In addition, the
comparison of the IC50 values for the compounds tested will enable for further
understanding of the structure-activity relation of flavonoids towards inhibition of
bacterial holo-ACC, BC, and CT, which helps accelerate the search for potent
inhibitors of these enzymes.
The offline assay of human ACC2 can be applied to quantify the IC50 values of
myricetin, quercetin, and anrantine osage orange. The inhibition study can be
expanded to other flavonoids to screen for structural leads. In addition, the offline CE
assay of human ACC2 can be extended to study human ACC1, which is an isozyme
of ACC2.
The CE coupled assay will be further developed for assays with lactate
dehydrogenase and pyruvate kinase as the coupling enzymes. These coupled assays
will then be applied to study ACC and PFK-1, which catalyze enzymatic reactions that
involve the consumption or production of ADP. These are two enzymes that have been
previously extensively researched in our lab. These CE-based coupled assays will be
subsequently applied to study inhibition of ACC and PFK-1 to avoid the spectral and
inhibitor interferences of coupled enzyme assays.
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APPENDIX A. CAPILLARY ELECTROPHORETIC ONLINE
COUPLED ENZYME ASSAY
Introduction
Capillary electrophoresis (CE) has emerged in recent years as an analytical
technique with applications in pharmaceuticals research [1, 2], especially for assay
development to study enzyme kinetics and inhibition [1, 3]. This is attributed to the low
sample consumption (nL), fast separation, and high separation efficiency in CE [4]. In
a CE enzyme assay, the reaction mixture can be incubated prior to being injected to
the capillary for subsequent separation (offline assay) or all involved steps including
mixing, incubation, and separation can occur inside the capillary (online assay). The
reaction progress is then monitored by detecting the formation of products and/or
depletion of substrates.
The first CE online enzyme assay was reported by Bao et al. [5]. Since then, a
wide variety of enzymes have been assayed using this technique [1, 6]. Based on the
physical states of the enzymes, CE online enzyme assays can be classified into two
categories: homogeneous and heterogenous assays. In a homogeneous assay, all
assay reagents including the enzyme are in aqueous form. Alternatively, for a
heterogeneous assay, the enzyme is normally immobilized onto the capillary surface,
incorporated in a polymer network, or immobilized onto a solid support to form
immobilized microenzyme reactors (IMERs). Compared to free enzymes, the
immobilized enzymes are more stable upon exposure to heat or different pHs [1]. In
addition, immobilized enzymes can be reused, making heterogeneous assays more
cost-efficient. Magnetic beads (MBs) have been used widely as the solid supports for
enzyme immobilization owing to their high surface to volume ratio, reusability, and the
ease of manipulating the location of the microreactors using an external magnetic field
[1]. Most MB-based assays were developed on CE with air-based cooling systems [1,
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7-12]. The orientation of the magnets along the capillary was studied by both
simulations and experiments [7, 9, 12, 13]. The two magnets configurations have been
commonly adopted: repulsive arrangement at either 20o or 30o, and attractive
arrangement at 90o (perpendicular) to the capillary. Experimental results indicated that
relative to the attractive arrangement at 90o, the pair of magnets when positioned in
repulsive configuration at 30o resulted in lower enzyme activity but higher
reproducibility [7, 13]. In addition to the magnet positions, the chemistry of the
functional groups on the MBs is also important for the formation and retention of the
MBs inside the capillary [8]. Recently, attempts have been made to develop CE online
assays in liquid-based cooling system, in which the coolant tubing made it difficult to
align the magnets in proximity to the capillary, posing as an obstacle for the magnet
holder design [13, 14]. Ramana et al. reported the ensemble of 1×1×1 mm magnets
along the capillary and inside the coolant tubing [14]. In another study, the same group
compared the online assays developed on the air-based and liquid coolant-based
systems. In the latter system, the magnets were positioned outside the coolant tubing,
in attractive orientation, and at an angle of 30o to the capillary [13]. The capturing
efficiency of the MBs in the liquid coolant-based CE system was lower compared to
the air-based system owing to the longer distance between magnet-magnet and
magnet-capillary.
Enzyme assays are based on the detection of either substrate depletion or
product formation. However, for some enzymatic reactions, it is not convenient to
detect the substrates and products. In such cases, in addition to the primary enzymes,
coupling enzymes are also utilized for indirect detection of the substrates or products.
Such assays, which are referred to as coupled enzyme assays, have been used widely
in biomedical research [15]. Traditional coupled assays are usually carried out in
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cuvettes or plate readers, which are prone to spectral interference since the measured
signal is attributed to not only the final product but also other assay components. The
use of CE for coupled enzyme assays can minimize the spectral interference by
separating the assay components prior to detection. Furthermore, small amounts of
assay reagents (nL-µL) are needed for the CE assay compared to the conventional
coupled assays (µL-mL).
In CE, fluorescence detection is the second common detection method, yet
offers the lowest limit of detection. Lasers have been used as the light sources for
fluorescence detection in CE owing to its high power, monochromatic, collimated, and
coherent output. Since its first introduction by Zare and coworkers [16], CE with laserinduced fluorescence detection (CE-LIF) has been applied to study biological samples
including peptides and proteins [17]. The quest for cheaper, more stable excitation
sources for fluorescence detection has extended to light-emitting diodes (LEDs).
In this work, a CE coupled online assay was developed on a commercial CE
system with liquid coolant. Lactate dehydrogenase (LDH) was used as a coupling
enzyme for the indirect detection of pyruvate, which is a product form in the puruvate
kinase (PK)-catalyzed reaction:
Pyruvate kinase

ADP + phosph(enol)pyruvate ⎯⎯⎯⎯⎯⎯⎯⎯⎯ ATP + Pyruvate
Lactate Dehydrogenase

Pyruvate + NADH ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯

Lactate + NAD

+

For this assay, LDH was immobilized onto the MBs, which formed the MB plug
inside the capillary in the presence of the external magnetic field. The reaction
progress was monitored based on the depletion of NADH, which was detected as a
negative peak by fluorescence detection using an LED as the excitation source.
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Materials and Methods
Chemicals
Puruvate kinase, L-lactic dehydrogenase from rabbit muscle, pyruvate, NADH,
NAD+,

MES,

1-ethyl-3-(3-dimethylaminopropyl)

carbodiimide

(EDC),

sodium

hydroxide, potassium bicarbonate, potassium citrate, magnesium chloride, and
HEPES were purchased from Sigma-Aldrich (St. Louis, MO). The Superparamagnetic
beads (Dynabeads M-270, 2.8 µm diameter, 30 mg/mL, 2 x 109 beads functionalized
with carboxylic acid) were purchased from Invitrogen Dynal (Oslo, Norway). Solutions
were prepared using ultrapure water (>18 MΩ, Barnstead Nanopure, ThermoFisher,
Marietta, Ohio, USA). Buffer solutions were filtered through 0.2 µm membranes
(Whatman, Hilsboro, OR, USA) before use.
Instrumentation
A P/ACE MDQ with a LIF detector module from Beckman Coulter (Brea, CA,
USA) was used for the CE coupled enzyme assays. Data were collected and analyzed
using 32 Karat 5.0 software from Beckman Coulter. Fused-silica capillary (50 µm id,
360 µm od) was purchased from Polymicro Technologies (Phoenix, Arizona, USA). A
short segment of the polyimide coating on the capillary was removed to create a
detection window using a MicroSolv CE window maker (Eatontown, NJ, USA). The
capillary total length was 42.5 cm, with an effective length of 32.5 cm (from the injection
end to the detection window). The 365-nm LED was purchased from Ocean Optics
(Winter Park, FL, USA). An optical fiber with a fiber core diameter of 200 µm and
numerical aperture of 0.29 (Ocean Optics, Dunedin, FL, USA) was coupled to the LED
by the SMA-905 connector. The maximum LED output power measured at the end of
the optical fiber was 0.5 mW. The band pass filter (475 nm, 25 nm band width, OD4,
12.5 mm diameter) was purchased from Edmund Optics, Inc. (Barrington, NJ, USA).
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LED emission spectral characterization was performed using an Avantes-2408
spectrometer (Broomfield, CO, USA). The optical filters were characterized using a
Varian Cary Eclipse UV-Vis spectrophotometer (Victoria, Australia). The excitation
and emission spectra of the NADH were collected using a Varian Cary Eclipse
fluorescence spectrophotometer (Victoria, Australia).
Magnet Configuration
The block magnets (1/2×1/4×1/4 in, NdFeB rare earth magnets, N52
magnetization, surface field 7123 Gauss, Brmax 1.48 T, with the polarization along the
longest dimension) were purchased from K&J Magnetics (Pipersville, PA, USA). The
coolant tubing was modified by inserting a 5.5-cm tubing of smaller size (1/8 inch od,
1/16 inch id) between two pieces of the original coolant tubing (3/8 inch od, 1/8 inch
id). The connections between two tubing types were secured by zip tights. When the
liquid coolant circulated in the modified cartridge, no leakage was detected. The
magnets were positioned against the edges of the smaller coolant tubing as shown in
Figure A1. As such, the magnets could be brought closer while the position of the
capillary inside the coolant tubing was controlled more accurately. The magnets were
separately glued onto two rectangular pieces of plastic (2.7×2.0 cm), which were then
fixed onto a rectangular piece of plastic (2.7×4.0 cm) by the nylon bolts. This design
allowed the two magnets to be arranged in repulsive orientation, at 20o to the capillary,
and 14.7 cm from the capillary inlet.
CE Conditions
For the CE assay, NADH was prepared in the buffer containing 30.0 mM
HEPES, 2.5 mM KHCO3, 3.0 mM MgCl2 at pH 7.50 daily due to the instability of NADH.
The resulting NADH-containing buffer was used as both the sample and separation
buffers. Other assay components (pyruvate, MBs) were also prepared in the NADH-
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containing buffer. The capillary was conditioned by rinsing with NaOH, water, and then
buffer for 10.0 min at 20.0 psi each. For the NADH separation experiment, the sample
was injected at 0.5 psi for 10s, followed by separation at 20.0 kV (470 V/cm). The
current conducted in the capillary was at 20.2 µA. The temperatures of both the sample
tray and the capillary were set at 25 °C.

Figure A1. Magnet holder set up for the coolant liquid-based catridge.
Enzyme Immobilization on MBs
The enzyme immobilization onto the MBs was carried out following the two-step
procedure suggested by the manufacturer, including the activation of the MB surface
with EDC and immobilization of the enzyme. Initially, 100 µL MBs (2×109 beads/mL,
or 30 mg beads/mL) was washed twice with 0.01 M NaOH and three times with cold
deionized water. Subsequently, 200 µL EDC (72.77 mg/mL, prepared in cold water)
was added to the MBs, and the mixture was incubated for 30 min at room temperature,
on a rocking platform. After the incubated was completed, the supernatant was
removed, and the MBs were washed again with cold deionized water and 50 mM MES

132

buffer (pH 5.0). Following the MB surface activation by EDC, 60 µL LDH (1.0 mg/mL,
prepared in 50 mM MES buffer pH 5.0) and 60 µL MES buffer were added to the MBs,
and the mixture was incubated at room temperature for 1 hour. Finally, the MBs were
washed with PBS buffer to remove the free enzyme in excess and block the unreacted
carboxylic acid. The MBs was resuspended to the concentration of 2×109 beads/mL
in 100 µL PBS buffer and stored at 2-8oC for later use. The working MB solution was
prepared by washing the MBs in NADH-containing solution for three time before
diluting the stock enzyme-immobilized MB solutions by 20 times in the NADHcontaining buffer to obtain the final concentration of 1×108 beads/mL.
Results and Discussion
Characterization of NADH, the LED, and the Optical Filter
The excitation and emission spectra of NADH, the transmission spectrum of the
band pass filter and the emission spectrum of the LED are shown in Figure A2. The
maximum excitation and emission wavelengths of NADH are at 339 nm and 464 nm,
respectively whereas the LED emitted light in a wide range of wavelength, with the
peak at 365 nm. Consequently, the overlap between the LED emission spectrum and
NADH excitation spectrum (Figure A2) enabled the fluorescence detection of NADH
using the LED as the excitation source. The band pass filter, which had the maximum
transmittance of 97.2%, coincided with the NADH emission spectrum right at its peak.
In addition to the passing band being far apart from the LED emission peak, the narrow
band width was an important feature of the band pass filter since it limited the stray
light from the LED to reach the detector.

133

Excitation NADH
360 nm laser
475 nm band pass filter
100

0.8

80

0.6

60

0.4

40

0.2

20

0.0

Transmittance (%)

Normalized Intensity

Emission NADH
LED emission
351 nm laser
1.0

0
200

300

400
500
Wavelength (nm)

600

Figure A2. Excitation and emission spectra of NADH, emission spectrum of the LED,
and transmission spectrum of the band pass filter
CE Separation and Detection of NADH
NADH was separated by CE in the separation buffer containing 30.0 mM
HEPES, 2.5 mM KHCO3, 3.0 mM MgCl2 at pH 7.50 and detected by fluorescence
detection. The limit of detection for NADH was 17.2 µM, which was 43 times higher
than the LOD reported by Henken et al [18]. Previously, Henken et al. reported the
detection of NADH using multiple laser lines at 351-360 nm as the excitation source,
with the output power of 3.0 mW, and a 365 nm band pass filter [18]. Eventually, the
LED light source output power, the overlap between the light source emission and
fluorophore excitation spectra as well as the band pass filter were all attributed to the
high LOD. First, the LED that was used as the excitation source for the fluorescence
detection of NADH in this project had the maximum output power of 0.5 mW, which
was 6-fold lower than the laser. Second, based on the overlap of the LED emission
and NADH excitation spectra, the adjusted excitation intensity calculated for this
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source-fluorophore was 0.555. For the laser lines at 351 nm and 360 nm, the adjusted
excitation intensities were 0.724 and 0.882, respectively. Therefore, the excitation of
NADH was 1.3 to 1.5-fold less effective when using the LED. Third, although the band
pass filter with a narrow width (central wavelength at 475 nm, 25 nm band width)
enabled the collection of NADH fluorescence near the emission peak, a small tail of
the LED emission still passed through the filter (Figure A3). The LED emission at long
wavelengths (442-515 nm) made up 0.09% of the fluorescence signal.
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Figure A3. The zoom-in spectra of the LED and band pass filter
For the LDH online enzyme assay, the concentration of NADH in the separation
buffer affects not only the product formation but also the background signal. According
to Shi et al., in the online assay of immobilized LDH, when the NADH concentration
was at and above 0.25 mM, the NADH consumption peak height approached
maximum [10]. To study the effect of NADH concentration in the separation buffer on
the NADH consumption peak, the electropherograms obtained with two separation
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buffers containing 0.25 mM and 1.0 mM NADH were compared. Figure A4 shows the
separation of the samples whose NADH concentrations were 100 µM lower than the
concentration of NADH in the separation buffers. The CE separation of 900 µM NADH
in the separation buffer containing 1.0 mM NADH resulted in a negative peak of NADH.
Similarly, 100 µM NADH when separated in the separation buffer containing 0.25 mM
NADH was also detected as a negative peak, but without the big artifact peak in the
front. Therefore, the separation buffer containing 30.0 mM HEPES, 2.5 mM KHCO3,
3.0 mM MgCl2, and 0.25 mM NADH at pH 7.50 was used for further development of
the LDH online assay.
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Figure A4. Electropherograms for the separation of 100 µM NADH in the separation
buffer containing 0.25 mM NADH (red) and 900 µM NADH in the separation buffer
containing 1.0 mM NADH (black).
The calibration curve for direct detection of NADH was y=0.0017x – 0.0071 (R2
= 0.997). However, for the coupled assay, NADH was detected as a negative peak
due to NADH consumption. Therefore, it was practical to establish the calibration curve
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of the depleted NADH. Figure A5 shows the calibration of NADH, provided that the
concentration of NADH in the sample was 25-200 µM lower than the concentration of
NADH in the separation buffer.
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Figure A5. Calibration curve of NADH
Offline Assay of the Immobilized Enzyme
In order to test the activity of the immobilized LDH, the LDH-immobilized MBs
(at the final concentration of 2×107 beads/mL) were incubated with 1.0 mM pyruvate
in a buffer containing 30.0 mM HEPES, 2.5 mM KHCO3, 3.0 mM MgCl2, and 0.25 mM
NADH at pH 7.50. Following the hydrodynamic injection at 0.5 psi for 10.0 s, the
reaction mixture was separated at 20.0 kV (470 V/cm) in the separation buffer that
contained 30.0 mM HEPES, 2.5 mM KHCO3, 3.0 mM MgCl2, and 0.25 mM NADH at
pH 7.50. The control contained all components except for the LDH-immobilized MBs.
The electropherograms for the offline assay of the LDH-immobilized MBs are shown
in Figure A6.
Upon the incubation of the LDH-immobilized MBs with pyruvate in the NADHcontaining buffer, a negative peak corresponding to the consumption of NADH was
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observed. This NADH peak height increased as the reaction time extended from 3 min
to 20 min. This result indicated that the immobilized LDH on the MBs was active.
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Figure A6. Offline assay of the LDH-immobilized MBs
Online Assay of the Immobilized Enzyme
The formation and retention of the MB plugs inside the capillary was
qualitatively studied under the microscope, on a homebuilt CE system. After the LDHimmobilized MBs (1×108 beads/mL) were manually injected to the capillary using a
syringe, a plug of MBs were observed. Subsequently, upon the application of 10 kV
(235 V/cm) for 30 min and 20 kV (470 V/cm), the MB plug still remained in the capillary
in between the two magnets.
For the online assay, both the sample buffer and the separation buffer
contained 30.0 mM HEPES, 2.5 mM KHCO3, 3.0 mM MgCl2, and 0.25 mM NADH at
pH 7.50, which is also referred to as the NADH-containing buffer hereafter. Pyruvate
and the MBs for the online assay were prepared in the NADH-containing buffer.
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Initially, the LDH-immobilized MBs (1×108 beads/mL) were injected to the capillary at
0.5 psi for 60.0 s. Low pressure (0.5 psi) was applied for 10.0 min to transport the MBs
to the magnetic field. Afterwards, 1.0 mM pyruvate was injected to the capillary under
0.5 psi for 10.0 s. The plug of pyruvate was moved under 0.5 psi for 4.2 min to the
IMER position where the reaction was let incubated for 10.0 min. Finally, the assay
components were separated, and the NADH which was consumed was detected as a
negative peak, as shown in Figure A7.
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Figure A7. Online assay of LDH. The MBs were hydrodynamically injected at 0.5 psi
for 60.0s and moved to the magnetic field under 0.5 psi for 10.0 min. The 1.0 mM
pyruvate substrate was injected at 0.5 psi for 10.0s, then moved to the IMER position
under 0.5 psi for 4.2 min. After 10.0 min incubation, the reaction was stopped upon
the application of 20.0 kV (470 V/cm). The separation buffer contained 30.0 mM
HEPES, 2.5 mM KHCO3, 3.0 mM MgCl2, and 0.25 mM NADH at pH 7.50.
In control 1, the NADH-free buffer was injected as a sample to determine the
migration time for NADH which was at 5.2 min in the online assay. Compared to the
separation of NADH in Figure A4 and Figure A6, the peak of NADH in the online assay
presented in Figure A7 was broader while the migration time of NADH was 2 fold
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shorter as a result of the additional step involving the transport of the pyruvate plug to
the IMERs position under pressure. In control 2, following the same procedure
described for the online assay, instead of the pyruvate, the NADH-containing buffer
was injected and separated. In addition, in the absence of the MBs, the sample
containing 1.0 mM pyruvate and 0.25 mM NADH was injected to the capillary as
control 3. In both control 2 and control 3, no negative peak for NADH was observed.
For the online assay, a negative peak corresponding to the NADH consumption was
observed, indicating that the immobilized LDH was active in the online assay.
0.3

NADH

120 s

0.2

RFU

60 s
0.1

30 s

0.0

-0.1
2

4

6
Time (min)

8

10

Figure A8. Dependence of NADH peak height on the LDH-MBs injection time. The
MBs were injected at 0.5 pi for 30s, 60s, and 120 s. Other experimental conditions
were the same as described in Figure A7.
The amount of MBs injected to the capillary is an important factor that affects
the assay response. The dependence of the NADH peak on the duration of MB
injection is shown in Figure A8. At the same MBs stock concentration, the number of
MBs injected to the capillary depends on the pressure and injection time. Under the
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injection pressure of 0.5 psi, as the MBs injection time was increased from 30 to 120
s, the NADH peak height increased accordingly. The dependence of NADH peak
height on the concentration of the pyruvate substrate was shown in Figure A9. The
pyruvate concentration at 1.0 mM yielded higher NADH peak height than the assay
with 0.5 mM pyruvate.
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Figure A9. Dependence of the NADH peak height on the concentration of the pyruvate
substrate. The 0.5 mM and 1.0 mM pyruvate substrate solutions were injected
hydrodynamically at 0.5 psi. Other experimental conditions were the same as
described in Figure A7.
Conclusion
A CE online assay of LDH was developed on a liquid coolant-based system. In
this assay, LDH was immobilized onto MBs, which were subsequently held inside the
capillary by a pair of magnets. The online LDH assay was studied based on the
detection of the NADH consumption, which was detected as a negative peak using
fluorescence detection. An LED was utilized as the excitation source for NADH
detection, yielding the LOD of 17.2 µM. The primary data showed that the LDH-
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immobilized MBs retained inside the capillary and exhibited enzyme activity in the
online assay. This work served as a basis for the CE online coupled assay that uses
lactate dehydrogenase and pyruvate kinase as the coupling enzymes and can be
extended for online coupled assays that use multiple coupling enzymes.
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